Patient groups - The 糖心原创

CEBD Coronavirus Dermatology Resource

Journal articles - Coronavirus and specific patient groups other than psoriasis

Atopic dermatitis

Skin cancers

Hidradenitis suppurativa

Bullous diseases

Paediatric

Other conditions and groups

Please see also Guidelines page and Coronavirus and Psoriasis

Atopic dermatitis

Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.
Ring J, Worm M, Wollenberg A, Thyssen JP, Jakob T, Klimek L, Bangert C, Barbarot S, Bieber T, de Bruin-Weller MS, Chernyshov PV, Christen-Zaech S, Cork M, Darsow U, Flohr C, Fölster-Holst R, Gelmetti C, Gieler U, Gutermuth J, Heratizadeh A, Hijnen DJ, von Kobyletzki LB, Kunz B, Paul C, De Raeve, Seneschal J, Simon D, Spuls PI, Stalder JF, Svensson A, Szalai Z, Taieb A, Torrelo A, Trzeciak M, Vestergaard, Werfel T, Weidinger S, Deleuran M.
J Eur Acad Dermatol Venereol. 2021 Mar 22. doi: 10.1111/jdv.17237. Online ahead of print. Review & recommendations.

Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single centre, cross-sectional study.
Yiu ZZN, Harding G, Griffiths CEM, Warren RB, McMullen E, Hunter HJA. Cross-sectional study.
Br J Dermatol. 2021 Mar 17. doi: 10.1111/bjd.20062. Online ahead of print.

COVID-19-associated surge of atopic dermatitis.
[No authors listed]
EBioMedicine. 2021 Feb;64:103268. doi: 10.1016/j.ebiom.2021.103268. Editorial.

Young HIV-positive male patient with severe atopic dermatitis on dupilumab and SARS-CoV-2 infection, a pioneer hypothesis.
Ordóñez-Rubiano MF, Rubiano-Mojica PC, Casas M.
Int J Dermatol. 2021 Feb 28. doi: 10.1111/ijd.15499. Online ahead of print. Case report.

European Task Force on Atopic Dermatitis (ETFAD): position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics.
Thyssen JP, Vestergaard C, Barbarot S, de Bruin-Weller MS, Bieber T, Taieb A, Seneschal J, Cork MJ, Paul C, Flohr C, Weidinger S, Trzeciak M, Werfel T, Heratizadeh A, Darsow U, Simon D, Torrelo A, Chernyshov PV, Stalder JF, Gelmetti C, Szalai Z, Svensson Å, von Kobyletzki LB, De Raeve L, Fölster-Holst R, Christen-Zaech S, Jan Hijnen D, Gieler U, Gutermuth J, Bangert C, Spuls PI, Kunz B, Ring J, Wollenberg A, Deleuran M.
J Eur Acad Dermatol Venereol. 2021 Feb 15. doi: 10.1111/jdv.17167. Online ahead of print. Guideline.

COVID-19 and biologic therapies in dermatology: seroprevalence survey and severity analysis in a tertiary hospital in Spain.
Barrutia L, Volo V, Ruíz-Sánchez D, Valtueña J, Aguado García A, Manchado López P.
Int J Dermatol. 2021 Feb 9. doi: 10.1111/ijd.15467. Online ahead of print. Cross-sectional study.

Topical steroids and topical tacrolimus appear safe regarding in relation to the COVID-19 epidemic.
Souaid K, Klejtman T, Kramkimel N, Isnard C, Dupin N, Aractingi S.
Ann Dermatol Venereol. 2021 Jan 8:S0151-9638(21)00003-X. doi: 10.1016/j.annder.2020.12.001. Online ahead of print. Cohort study.

Adherence to biological therapy in dermatological patients during the COVID-19 pandemic in Western Sicily.
Tilotta G, Pistone G, Caruso P, Gurreri R, Castelli E, Curiale S, Caputo V, Bongiorno MR.
Int J Dermatol. 2021 Feb;60(2):248-249. doi: 10.1111/ijd.15352. Epub 2020 Dec 8. Cross-sectional study / audit.

Asthma and allergic diseases are not risk factors for hospitalization in children with COVID-19.
Beken B, Ozturk GK, Aygun FD, Aydogmus C, Akar HH.
Ann Allergy Asthma Immunol. 2021 Jan 22:S1081-1206(21)00053-3. doi: 10.1016/j.anai.2021.01.018. Online ahead of print. Cross-sectional study.

Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.
Patrick MT, Zhang H, Wasikowski R, Prens EP, Weidinger S, Gudjonsson JE, Elder JT, He K, Tsoi LC.
J Allergy Clin Immunol. 2021 Jan 21:S0091-6749(21)00084-1. doi: 10.1016/j.jaci.2021.01.006. Online ahead of print. Genetic meta-analysis.

Biologics for atopic diseases: Indication, side effect management, and new developments.
Jappe U, Beckert H, Bergmann KC, Gülsen A, Klimek L, Philipp S, Pickert J, Rauber-Ellinghaus MM, Renz H, Taube C, Treudler R, Wagenmann M, Werfel T, Worm M, Zuberbier T.
Allergol Select. 2021 Jan 5;5:1-25. doi: 10.5414/ALX02197E. eCollection 2021. Commentary.

Dermatologic comorbidities of the patients with severe COVID-19: A case-control study.
Kutlu Ö, Demirel Öğüt N, Erbağcı E, Metin A.
Dermatol Ther. 2021 Jan 2. doi: 10.1111/dth.14731. Online ahead of print. Case-control study.

Association of skin diseases, biological treatment and COVID-19 during the first wave of the pandemic.
Descalzo MA, Garcia-Doval I.
Br J Dermatol. 2020 Dec 4. doi: 10.1111/bjd.19683. Online ahead of print. Commentary.

Rare atopy in COVID-19 patients or COVID-19 famine in atopic patients?
Naziroğlu T, Aksu K.
Dermatol Ther. 2020 Nov 25. doi: 10.1111/dth.14581. Online ahead of print. Cross-sectional study.

COVID-19 and allergy: How to take care of allergic patients during a pandemic?
Cianferoni A, Votto M.
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26:96-101. doi: 10.1111/pai.13367. Review.

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic.
Yim RM, Singh I, Armstrong AW.
Dermatol Online J. 2020 Oct 15;26(10):13030/qt0j5150df. Summary of international guidelines.

COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data.
de Wijs LEM, Joustra MM, Olydam JI, Nijsten T, Hijnen DJ.
J Eur Acad Dermatol Venereol. 2020 Nov 1. doi: 10.1111/jdv.17025. Online ahead of print. Survey / cross-sectional study.

Evaluation of the effect of COVID-19 pandemic on dermatological diseases with Dermatological Quality Life Index.
Daye M, Temiz SA, Işık B, Dursun R, Ataseven A.
Dermatol Ther. 2020 Oct 6:e14368. doi: 10.1111/dth.14368. Online ahead of print. Prospective cohort study.

Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era.
Patella V, Delfino G, Florio G, Spadaro G, Chieco Bianchi F, Senna G, Di Gioacchino M.
Clin Mol Allergy. 2020 Oct 1;18:18. doi: 10.1186/s12948-020-00134-5. eCollection 2020. Review & recommendations.

Effects of lockdown on health of patients with severe atopic dermatitis treated with dupilumab.
Ferrucci SM, Tavecchio S, Favale EM, Angileri L, Riva D, Romagnuolo M, Beretta AE, Marzano AV.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16955. Online ahead of print. Cohort study.

Role of dupilumab in approved indications of COVID-19 patient: an efficacy-based nonsystematic critical analysis.
Thangaraju P, Venkatesan N, Sudha TYS, Venkatesan S, Thangaraju E.
SN Compr Clin Med. 2020 Sep 10:1-5. doi: 10.1007/s42399-020-00510-x. Online ahead of print. Review / commentary.

COVID‐19 und Auswirkungen auf dermatologische und allergologische Erkrankungen.
Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M.
J Dtsch Dermatol Ges. 2020 Aug;18(8):815-825. doi: 10.1111/ddg.14195_g. Review. German.

Wearing a mask and skin disease: patients with atopic dermatitis speak it out.
Merhand S, Misery L, Delvigne V, Le Floch C, Taïeb C.
J Eur Acad Dermatol Venereol. 2020 Sep 3. doi: 10.1111/jdv.16917. Online ahead of print. Survey / cross-sectional study.

Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study.
Yang JM, Koh HY, Moon SY, Yoo IK, Ha EK, You S, Kim SY, Yon DK, Lee SW.
J Allergy Clin Immunol. 2020 Aug 15:S0091-6749(20)31136-2. doi: 10.1016/j.jaci.2020.08.008. Online ahead of print. Cohort study.

Atopic status protects from severe complications of COVID-19.
Scala E, Abeni D, Tedeschi A, Manzotti G, Yang B, Borrelli P, Marra A, Giani M, Sgadari A, Saltalamacchia F, Asero R.
Allergy. 2020 Aug 16. doi: 10.1111/all.14551. Online ahead of print. Cross-sectional study.

Dupilumab in atopic dermatitis, a protocol for SARS-COV 2 infected patients.
Ordóñez-Rubiano MF, Campo I, Casas M.
Dermatol Ther. 2020 Aug 10:e14172. doi: 10.1111/dth.14172. Online ahead of print. Case report / commentary.

Concerns related to the COVID-19 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey.
Dyrberg Loft N, Halling AS, Iversen L, Vestergaard C, Deleuran M, Rasmussen MK, Zachariae C, Thyssen JP, Skov L.
J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16863. Online ahead of print. Survey.

Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registries.
Gadarowski MB, Balogh EA, Bashyam AM, Feldman SR.
J Dermatolog Treat. 2020 Aug 8:1-17. doi: 10.1080/09546634.2020.1808154. Online ahead of print. Review.
Biologic drugs during COVID-19 outbreak.
Montesu MA, Biondi G, Sotgiu G, Sucato F, Satta R.
Int J Dermatol. 2020 Aug 6. doi: 10.1111/ijd.15088. Online ahead of print. Cohort study.

COVID-19 and immunosuppressive therapy in dermatology.
Schwartz RA, Pradhan S, Murrell DF, Jafferany M, Olisova OY, Lomonosov KM, Lotti T, Goldust M.
Dermatol Ther. 2020 Aug 7:e14140. doi: 10.1111/dth.14140. Online ahead of print. Review / recommendations.

Impact of the COVID-19 pandemic on chronic inflammatory dermatoses: Mixed messages regarding the dermatologist's point of view and the patient's concerns.
Fougerousse AC, Maccari F, Reguiai Z, Begon E, Pallure V, Taïeb C, Girard C, Mery-Bossard L.
Acta Derm Venereol. 2020 Jul 31. doi: 10.2340/00015555-3610. Online ahead of print. Commentary.

COVID-19 and implications for dermatological and allergological diseases.
Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M.
J Dtsch Dermatol Ges. 2020 Jul 27. doi: 10.1111/ddg.14195. Online ahead of print. Review.

Atopy is predictive of a decreased need for hospitalization for COVID-19.
Keswani A, Dhana K, Rosenthal JA, Moore D, Mahdavinia M.
Ann Allergy Asthma Immunol. 2020 Jul 18:S1081-1206(20)30489-0. doi: 10.1016/j.anai.2020.07.012. Online ahead of print. Cohort study.

Risk of COVID-19 in dermatologic patients on long-term immunomodulatory therapy.
Holcomb ZE, Santillan MR, Morss-Walton PC, Salian P, Her MJ, Giannotti NM, Kimball AB, Porter ML.
J Am Acad Dermatol. 2020 Jul 1. pii: S0190-9622(20)32099-5. doi: 10.1016/j.jaad.2020.06.999. [Epub ahead of print] No abstract available. Retrospective cross-sectional study.

Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic.
Kearns DG, Uppal S, Chat VS, Wu JJ.
J Am Acad Dermatol. 2020 Jun 10. pii: S0190-9622(20)31075-6. doi: 10.1016/j.jaad.2020.06.015. [Epub ahead of print] No abstract available. Review / commentary.

Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
Du H, Dong X, Zhang JJ, Cao YY, Akdis M, Huang PQ, Chen HW, Li Y, Liu GH, Akdis CA, Lu XX, Gao YD.
Allergy. 2020 Jun 10. doi: 10.1111/all.14452. [Epub ahead of print]. Cross-sectional study.

Management of adult patients with severe atopic dermatitis treated with dupilumab during COVID-19 pandemic: a single-center real-life experience.
Rossi M, Rovati C, Arisi M, Soglia S, Calzavara-Pinton P.
Dermatol Ther. 2020 Jun 4:e13765. doi: 10.1111/dth.13765. [Epub ahead of print] No abstract available. Case series.

Considerations for safety in the use of systemic medications for psoriasis and atopic dermatitis during the COVID-19 pandemic.
Ricardo JW, Lipner SR.
Dermatol Ther. 2020 May 27. doi: 10.1111/dth.13687. [Epub ahead of print]. Review.

COVID-19, quarantine, and atopic dermatitis.
Patruno C, Nisticò SP, Fabbrocini G, Napolitano M.
Med Hypotheses. 2020 May 19;143:109852. doi: 10.1016/j.mehy.2020.109852. [Epub ahead of print] No abstract available. Commentary.

Evidenced-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19.
Galimberti F, McBride J, Cronin M, Li Y, Fox J, Abrouk M, Herbst A, Kirsner RS.
Clin Dermatol. 2020 May 14. doi: 10.1016/j.clindermatol.2020.05.003. [Epub ahead of print]. Review / recommendations.

Safety of dupilumab in atopic patients during COVID-19 outbreak.
Napolitano M, Patruno C, Ruggiero A, Nocerino M, Fabbrocini G.
J Dermatolog Treat. 2020 May 18:1-5. doi: 10.1080/09546634.2020.1771257. [Epub ahead of print] No abstract available. Survey / cross-sectional study.

Optimizing care for atopic dermatitis patients during COVID-19 pandemic.
Shah M, Sachdeva M, Alavi A, Shi VY, Hsiao JL.
J Am Acad Dermatol. 2020 May 13. doi: 10.1016/j.jaad.2020.05.027. [Epub ahead of print] No abstract available. Commentary / management recommendations.

SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.
Caroppo F, Biolo G, Belloni Fortina A.
J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16619. [Epub ahead of print]. Case report.

Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
Kutlu Ö, Metin A.
Dermatol Ther. 2020 May 5:e13509. doi: 10.1111/dth.13509. [Epub ahead of print]. Case series.

Dupilumab and COVID-19: what should we expect?
Patruno C, Stingeni L, Fabbrocini G, Hansel K, Napolitano M.
Dermatol Ther. 2020 May 2. doi: 10.1111/dth.13502. [Epub ahead of print]. Commentary.

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
Mahil SK, Yiu ZZN, Mason KJ, Dand N, Coker B, Wall D, Fletcher G, Bosma A, Capon F, Iversen L, Langan SM, Di Meglio P, Musters A, Prieto-Merino D, Tsakok T, Warren RB, Flohr C, Spuls P, Griffiths CEM, Barker J, Irvine AD, Smith CH; Secure-AD, PsoPROTECT study groups.
Br J Dermatol. 2020 Apr 29. doi: 10.1111/bjd.19161. [Epub ahead of print]. Letter/commentary.

No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.
Carugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, Robustelli Test E, Sena P.
J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16552. [Epub ahead of print]. Case series.

Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports.
Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S.
J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16527. [Epub ahead of print]

Skin cancers

The role of teleconsultation in the management of suspected skin malignancy in plastic surgery during COVID-19 outbreak: A single centre experience.
Koysombat K, Plonczak AM, West CA.
J Plast Reconstr Aesthet Surg. 2021 Mar 19:S1748-6815(21)00092-9. doi: 10.1016/j.bjps.2021.03.003. Online ahead of print. Cohort study.

Unemployment and health-related quality of life in melanoma patients during the COVID-19 pandemic.
Guo Y, Shen M, Zhang X, Xiao Y, Zhao S, Yin M, Bu W, Wang Y, Chen X, Su J.
Front Public Health. 2021 Feb 22;9:630620. doi: 10.3389/fpubh.2021.630620. eCollection 2021. Cross-sectional study.

Impact of the SARS-CoV-2 pandemic on the early diagnosis of melanoma.
Fernández Canedo MI, de Troya Martín M, Rivas Ruíz F.
Med Clin (Engl Ed). 2021 Mar 3. doi: 10.1016/j.medcle.2020.12.006. Online ahead of print. Retrospective cross-sectional study.

Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospital.
Valenti M, Pavia G, Gargiulo L, Facheris P, Nucca O, Mancini L, Sacrini F, Borroni RG, Narcisi A, Costanzo A.
Int J Dermatol. 2021 Mar 4. doi: 10.1111/ijd.15501. Online ahead of print. Retrospective case-control study.

COVID-19 impacts on dermatologic surgery patients: a single institution experience.
Danesh MJ, Porter M, Brag K, Salian P, Olbricht S.
J Am Acad Dermatol. 2021 Feb 25:S0190-9622(21)00425-4. doi: 10.1016/j.jaad.2021.02.060. Online ahead of print. Cross-sectional study / audit.

Bare necessities? The utility of full skin examination in the COVID19 era.
O'Connor C, Gallagher C, O'Connell M, Bourke J, Murphy M, Bennett M.
Clin Exp Dermatol. 2021 Feb 27. doi: 10.1111/ced.14620. Online ahead of print. Research study.

Impact of COVID-19 on melanoma diagnosis.
Weston GK, Jeong HS, Mu EW, Polsky D, Meehan SA.
Melanoma Res. 2021 Feb 18. doi: 10.1097/CMR.0000000000000717. Online ahead of print. Cross-sectional study / audit.

Impact of the SARS-CoV-2 pandemic on the early diagnosis of melanoma.
Fernández Canedo MI, de Troya Martín M, Rivas Ruíz F.
Med Clin (Barc). 2021 Jan 28:S0025-7753(21)00019-1. doi: 10.1016/j.medcli.2020.12.011. Online ahead of print. Spanish (English version to follow). Retrospective case review.

Management of melanoma patients during COVID-19 pandemic in an Italian skin unit.
Filoni A, Paolo DF, Cappellesso R, Dall'Olmo L, Salimian N, Spina R, Tropea S, Rastrelli M, Russano F, D'Amico M, Collodetto A, Rossi CR, Buja A, Vecchiato A, Alaibac M, Mocellin S.
Dermatol Ther. 2021 Feb 22:e14908. doi: 10.1111/dth.14908. Online ahead of print. Retrospective case review.

Impact of the COVID-19 pandemic on dermatology practice worldwide: Results of a survey promoted by the International Dermoscopy Society (IDS).
Conforti C, Lallas A, Argenziano G, Dianzani C, Di Meo N, Giuffrida R, Kittler H, Malvehy J, Marghoob AA, Soyer HP, Zalaudek I.
Dermatol Pract Concept. 2021 Jan 29;11(1):e2021153. doi: 10.5826/dpc.1101a153. eCollection 2021 Jan. Survey.

St Andrew's COVID-19 Surgery Safety (StACS) study: Skin cancer.
Miranda BH, Jica RCI, Pinto-Lopes R, Mopuri N, Sood MK, Tare M, Shelley O, El-Muttardi N; St Andrew’s Collaborative.
J Plast Surg Hand Surg. 2021 Feb 19:1-7. doi: 10.1080/2000656X.2021.1883633. Online ahead of print. Prospective cohort study.

Checkpoint inhibitor therapy for skin cancer may be safe in patients with asymptomatic COVID-19.
Trojaniello C, Vitale MG, Ascierto PA.
Ann Oncol. 2021 Feb 15:S0923-7534(21)00125-3. doi: 10.1016/j.annonc.2021.02.008. Online ahead of print. Cohort study.

COVID-19 and immune checkpoint inhibitors.
Ahmed MS, Brehme H, Friedrich S, Reinhardt L, Blum S, Beissert S, Meier F.
J Eur Acad Dermatol Venereol. 2021 Feb 15. doi: 10.1111/jdv.17172. Online ahead of print. Case report & commentary.

COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study.
Gonzalez-Cao M, Carrera C, Rodriguez Moreno JF, Rodríguez-Jiménez P, Antoñanzas Basa M, Feltes Ochoa R, Puertolas T, Muñoz E, Manzano JL, Marquez-Rodas I, Martín-Liberal J, Soria A, Criado PL, García Castaño A, Boada A, Ayala de Miguel P, Puig S, Crespo G, Luna Fra P, Aguayo Zamora C, Feito Rodríguez M, Valles L, Drozdowskyj A, Seral CM, Gardeazabal J, Villalobos L, Rosell R, Fernandez-Morales LA, Rodrigo A, Viteri S, Provencio M, Berrocal A; Spanish Melanoma Group (GEM).
J Am Acad Dermatol. 2021 Feb 10:S0190-9622(21)00337-6. doi: 10.1016/j.jaad.2021.02.013. Online ahead of print. Registry / cohort study.

Reduced melanoma referrals during COVID-19 lockdown.
Berry W, Tan K, Haydon A, Shackleton M, Mar VJ.
Aust J Gen Pract. 2021 Jan 22. doi: 10.31128/AJGP-COVID-45. Online ahead of print. Retrospective study / audit.

Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit.
Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Merli M, Tonella L, Ribero S, Fierro MT.
Future Oncol. 2021 Feb 3. doi: 10.2217/fon-2020-0997. Online ahead of print. Commentary.

Impact of the COVID-19 pandemic on cancer diagnoses in general and specialized practices in Germany.
Jacob L, Loosen SH, Kalder M, Luedde T, Roderburg C, Kostev K.
Cancers (Basel). 2021 Jan 22;13(3):408. doi: 10.3390/cancers13030408. Cross-sectional database study.

Dermatologic oncology and histopathology at a secondary care centre during the coronavirus disease 2019 pandemic.
De Vincentiis L, Mariani MP, Ferrara G.
Am J Dermatopathol. 2021 Feb 1;43(2):160-162. doi: 10.1097/DAD.0000000000001814. Research study / audit.

The magnitude of COVID-19's effect on the timely management of melanoma and non-melanoma skin cancers.
Marson JW, Maner BS, Harding TP, Meisenheimer J VII, Solomon JA, Leavitt M, Levin NJ, Dellavalle R, Brooks I, Rigel DS.
J Am Acad Dermatol. 2021 Jan 8:S0190-9622(21)00082-7. doi: 10.1016/j.jaad.2020.12.065. Online ahead of print. Cross-sectional study.

Skin cancer management during the COVID-19 pandemic.
Thomas J, Rossi AM.
Cutis. 2020 Dec;106(6):E4-E8. doi: 10.12788/cutis.0146. Commentary.

Treating melanoma in situ during a pandemic with telemedicine and a combination of imiquimod, 5-fluorouracil, and tretinoin.
Nahm WJ, Gwillim EC, Badiavas EV, Nichols AJ, Kirsner RS, Boggeln LH, Shen JT.
Dermatol Ther (Heidelb). 2021 Jan 17. doi: 10.1007/s13555-020-00473-w. Online ahead of print. Case report.

COVID-19 and HHV8 first spotted together: an affair under electron microscopy.
Leoni E, Cerati M, Finzi G, Lombardo M, Sessa F.
J Eur Acad Dermatol Venereol. 2021 Jan 18. doi: 10.1111/jdv.17123. Online ahead of print. Case report.

Risk assessment of surgical interventions performed on non-infected patients during COVID-19 pandemic.
Demiroz A, Aydin S, Yalcin CE, Arslan H.
Cureus. 2020 Nov 24;12(11):e11682. doi: 10.7759/cureus.11682. Cohort study / audit.

Prediction of sentinel node status using melanoma e-prognostic tools.
Butt S, Chin K, Proby C, Affleck A.
Clin Exp Dermatol. 2020 Dec 24. doi: 10.1111/ced.14543. Online ahead of print. Case reports & commentary.

The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experience.
Shannon AB, Sharon CE, Straker RJ 3rd, Miura JT, Ming ME, Chu EY, Karakousis GC.
J Am Acad Dermatol. 2020 Dec 19:S0190-9622(20)33225-4. doi: 10.1016/j.jaad.2020.12.034. Online ahead of print. Case-control / cross-sectional study.

SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry.
Moritz RKC, Gutzmer R, Zimmer L, Meier F, Ahmed MS, Sell S, Schlaak M, Kapp F, Sachse MM, Haferkamp S, Welzel J, Kähler KC, Weichenthal M.
Eur J Cancer. 2020 Nov 28:S0959-8049(20)31347-2. doi: 10.1016/j.ejca.2020.11.015. Online ahead of print. Registry / cohort study.

Part II: Accuracy of teledermatology in skin neoplasms.
Giavina-Bianchi M, Azevedo MFD, Sousa RM, Cordioli E.
Front Med (Lausanne). 2020 Nov 23;7:598903. doi: 10.3389/fmed.2020.598903. eCollection 2020. Retrospective cohort study.

Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers.
Saponara M, Pala L, Conforti F, Rubatto M, De Risi I, Spagnolo F, Guida M, Bossi P, Quaglino P, Queirolo P.
Ther Adv Med Oncol. 2020 Nov 20;12:1758835920977002. doi: 10.1177/1758835920977002. eCollection 2020. Retrospective cohort study.

Achieving 62-day targets in the management of skin cancer: Lessons learned and future directions for the post-COVID era.
Kiely AL, Patel C, Ismail A.
J Plast Reconstr Aesthet Surg. 2020 Nov 21:S1748-6815(20)30630-6. doi: 10.1016/j.bjps.2020.11.014. Online ahead of print. Commentary.

Communication: A safe skin cancer surgery set-up during the COVID-19 crisis.
Friebel TR, Rinkoff S, Jemec B.
J Plast Reconstr Aesthet Surg. 2020 Nov 1:S1748-6815(20)30541-6. doi: 10.1016/j.bjps.2020.10.044. Online ahead of print. Report / cohort study.

Major fall in urgent skin cancer referrals during the COVID-19 outbreak.
Rich H, O'Neill T.
J Plast Reconstr Aesthet Surg. 2020 Nov 8:S1748-6815(20)30584-2. doi: 10.1016/j.bjps.2020.10.087. Online ahead of print. Audit & commentary.

Characterising non-melanoma skin cancer undergoing surgical management during the COVID-19 pandemic.
Capitelli-McMahon H, Hurley A, Pinder R, Matteucci P, Totty J.
J Plast Reconstr Aesthet Surg. 2020 Nov 2:S1748-6815(20)30539-8. doi: 10.1016/j.bjps.2020.10.042. Online ahead of print. Retrospective case-control study.

Pyrexia by COVID-19 in a patient treated with dabrafenib/trametinib therapy.
Hashimoto H, Ito T, Ide T, Sasaki N, Hikichi S, Furue M.
J Dermatol. 2020 Nov 16. doi: 10.1111/1346-8138.15696. Online ahead of print. Case report.

Response to "Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic".
Murray G, Roche D, Ridge A, Hackett C, Tobin AM.
Br J Dermatol. 2020 Nov 5. doi: 10.1111/bjd.19667. Online ahead of print. Commentary.

Approach to skin malignancies in COVID-19 pandemic days.
Aslan Kayıran M, Karadag AS, Wollina U.
J Biol Regul Homeost Agents. 2020 Oct 26;34(6). doi: 10.23812/20-344-E. Online ahead of print. Editorial.

COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma.
Arenbergerova M, Gkalpakiotis S, Arenberger P, Fialova A, Pasek M.
J Dermatolog Treat. 2020 Oct 22:1-2. doi: 10.1080/09546634.2020.1822500. Online ahead of print. Case reports.

Plastic surgical management of skin cancer patients during the COVID-19 pandemic.
Rich H, Jones B, Malin I, Hemington-Gorse SJ, Cubitt JJ.
J Plast Reconstr Aesthet Surg. 2020 Sep 20:S1748-6815(20)30446-0. doi: 10.1016/j.bjps.2020.08.143. Online ahead of print. Report / commentary.

The effect of the COVID-19 pandemic on skin cancer surgery in the United Kingdom: a national, multi-centre, prospective cohort study and survey of Plastic Surgeons.
Nolan GS, Dunne JA, Kiely AL, Pritchard Jones RO; RSTNCOVID: Skin Collaborative, Jain A, Gardiner M.
Br J Surg. 2020 Sep 16. doi: 10.1002/bjs.12047. Online ahead of print. Cohort study & survey.

Pandemic medicine: the management of advanced melanoma during COVID-19.
Patrinely JR, Johnson DB.
Melanoma Manag. 2020 Jul 31;7(3):MMT45. doi: 10.2217/mmt-2020-0012. Editorial.

Attitudes of patients with skin tumors during the COVID-19 pandemic.
Porcar Saura S, Pons Benavent M, Guillén Climent S, García Vázquez A.
Actas Dermosifiliogr. 2020 Sep 6:S0001-7310(20)30310-0. doi: 10.1016/j.ad.2020.08.005. Online ahead of print. Survey / cross-sectional study. English, Spanish.

COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy.
da Costa CM, de Souza ZS, Real Salgues AC, Harada G, Marino Rodrigues Ayres PP, Vieira Nunes DB, Katz A, Munhoz RR.
Immunotherapy. 2020 Sep 9. doi: 10.2217/imt-2020-0193. Online ahead of print. Case report.

Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19.
Pala L, Conforti F, Saponara M, De Pas T, Giugliano F, Omodeo Salè E, Jemos C, Marco R, Andrea A, Quaglino P, Fava P, Fierro MT, Queirolo P.
Semin Oncol. 2020 Aug 7:S0093-7754(20)30087-7. doi: 10.1053/j.seminoncol.2020.07.010. Online ahead of print. Retrospective case series / audit.

Skin cancers: how to balance the risks and benefits of surgery during COVID-19 pandemic (a Northern Italy single-center experience).
Pavia G, Gargiulo L, Valenti M, Facheris P, Nucca O, Narcisi A, Borroni RG, Costanzo A.
Int J Dermatol. 2020 Aug 9. doi: 10.1111/ijd.15086. Online ahead of print. Report / audit.

The reduction in the detection of melanoma during the coronavirus disease 2019 (COVID-19) pandemic in a melanoma center of South Italy.
Villani A, Fabbrocini G, Scalvenzi M.
J Dermatolog Treat. 2020 Sep 2:1-4. doi: 10.1080/09546634.2020.1818674. Online ahead of print. Commentary.

Complete remission of an advanced basal cell carcinoma after only three-month treatment with sonidegib: report of a case and drug management during COVID-19 pandemic.
Villani A, Fabbrocini G, Costa C, Scalvenzi M.
Dermatol Ther. 2020 Sep 1:e14200. doi: 10.1111/dth.14200. Online ahead of print. Case report.

Deselecting melanoma patients for sentinel lymph node biopsy during COVID-19: Clinical utility of tumor molecular profiling.
Meves A, Eggermont AMM.
Mayo Clin Proc Innov Qual Outcomes. 2020 Jul 17. doi: 10.1016/j.mayocpiqo.2020.05.009. Online ahead of print. Commentary / case report.

Treating keratinocyte carcinomas with a combination of imiquimod, 5-fluorouracil, and tretinoin using store-and-forward telemedicine in the age of coronavirus disease 2019 to promote social distancing.
Nahm WJ, Shen J, Kirsner RS, Nichols AJ, Harris ZC, Phillips AR, Badiavas EV.
JAAD Case Rep. 2020 Jul 25. doi: 10.1016/j.jdcr.2020.07.024. Online ahead of print. Case series.

Melanoma diagnosis at the time of COVID-19.
Longo C, Pampena R, Fossati B, Pellacani G, Peris K.
Int J Dermatol. 2020 Aug 17. doi: 10.1111/ijd.15143. Online ahead of print. Commentary / report.

Patient perceptions of Mohs micrographic surgery during the COVID-19 pandemic and lessons for the next outbreak.
Nicholson P, Ali FR, Patalay R, Craythorne E, Mallipeddi R.
Clin Exp Dermatol. 2020 Aug 16. doi: 10.1111/ced.14423. Online ahead of print. Survey.

Recommendations for skin cancer consultation and surgery during COVID-19 pandemic.
Brochez L, Baurain JF, Del Marmol V, Nikkels A, Kruse V, Sales F, Stas M, Van Laethem A, Garmyn M.
J Eur Acad Dermatol Venereol. 2020 Aug 12. doi: 10.1111/jdv.16772. Online ahead of print. Commentary / recommendations.

Delayed melanoma diagnosis in the COVID-19 era: Increased breslow thickness in primary melanomas seen after the COVID-19 lockdown.
Ricci F, Fania L, Paradisi A, Di Lella G, Pallotta S, Sobrino L, Panebianco A, Annessi G, Abeni D.
J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16874. Online ahead of print. Cross-sectional study.

Reduction in skin cancer diagnoses in the UK during COVID-19 pandemic.
Andrew TW, Alrawi M, Lovat P.
Clin Exp Dermatol. 2020 Aug 5. doi: 10.1111/ced.14411. Online ahead of print. Research study / audit.

COVID-19 board: Our multidisciplinary cutaneous oncology tumor board during the coronavirus-19 pandemic.
Chow M, Jiang SIB.
Dermatol Surg. 2020 Jul 31. doi: 10.1097/DSS.0000000000002568. Online ahead of print. Report / commentary.

Melanoma and COVID-19: A narrative review focused on treatment.
Elmas ÖF, Demirbaş A, Düzayak S, Atasoy M, Türsen Ü, Lotti T.
Dermatol Ther. 2020 Jul 31. doi: 10.1111/dth.14101. Online ahead of print. Review.

COVID-19 and skin cancer management: French nation-wide questionnaire survey from real-life practice.
Nardin C, Puzenat E, Dalac S, Maubec E, Aubin F; GCC.
J Dermatolog Treat. 2020 Jul 29:1-6. doi: 10.1080/09546634.2020.1801972. Online ahead of print. Survey.

Surgical delay and mortality for primary cutaneous melanoma.
Guhan S, Boland G, Tanabe K, Lin W, Reddy B, Hawryluk EB, Sober AJ, Tsao H.
J Am Acad Dermatol. 2020 Jul 22:S0190-9622(20)32279-9. doi: 10.1016/j.jaad.2020.07.078. Online ahead of print. Review.

A significant reduction in the diagnosis of melanoma during the Covid-19 lockdown in a third level center in the north of Italy.
Barruscotti S, Giorgini C, Brazzelli V, Vassallo C, Michelerio A, Klersy C, Chiellino S, Tomasini CF.
Dermatol Ther. 2020 Jul 26. doi: 10.1111/dth.14074. Online ahead of print. Retrospective case review / audit.

Melanoma: A silver lining in the black cloud of Covid-19.
Kassir M, Podder I, Olisova OY, Lomonosov KM, Lotti T, Goldust M.
Dermatol Ther. 2020 Jul 26. doi: 10.1111/dth.14070. Online ahead of print. Commentary.

Comment on "Rescheduling of clinical activities and teleconsulting for public dermatology. Two prompt answers to COVID-19 emergency".
De Simone P, Iorio A, Ardigò M, Silipo V, Ferrari A, Morrone A, Frascione P.
Int J Dermatol. 2020 Jul 25. doi: 10.1111/ijd.15026. Online ahead of print. Commentary.

Skin cancer and COVID-19.
Goldust M, Agarwal K, Podder I, Navarini AA.
Dermatol Ther. 2020 Jul 23:e14050. doi: 10.1111/dth.14050. Online ahead of print. Commentary.

Immune checkpoint inhibition in the era of COVID-19.
Kurzhals J, Terheyden P, Langan EA.
Clin Exp Dermatol. 2020 Jul 8. doi: 10.1111/ced.14370. [Epub ahead of print]. Review.

On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19.
Gambichler T, Reuther J, Scheel CH, Becker JC.
J Immunother Cancer. 2020 Jul;8(2). pii: e001145. doi: 10.1136/jitc-2020-001145. Review.

Management of patients with melanoma and non-melanoma skin cancers in the coronavirus disease 2019 era.
Conforti C, di Meo N, Giuffrida R, Zalaudek I.
Chin Med J (Engl). 2020 Jun 9. doi: 10.1097/CM9.0000000000000930. [Epub ahead of print] No abstract available. Editorial.

Estimated effect of COVID-19 lockdown on skin tumor size and survival: An exponential growth model.
Tejera-Vaquerizo A, Cañueto J, Toll A, Santos-Juanes J, Jaka A, Ferrandiz-Pulido C, Sanmartín O, Ribero S, Moreno-Ramírez D, Almazán F, Fuente MJ, Podlipnik S, Nagore E.
Actas Dermosifiliogr. 2020 May 11. pii: S0001-7310(20)30142-3. doi: 10.1016/j.ad.2020.05.001. [Epub ahead of print] Review. English, Spanish. Observational cohort study & model.

Severity and risk of COVID-19 in cancer patients: An evidence based learning.
Sharma A, Malviya R, Kumar V, Gupta R, Awasthi R.
Dermatol Ther. 2020 Jun 8:e13778. doi: 10.1111/dth.13778. [Epub ahead of print]. Review.

Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience.
Cinelli E, Fabbrocini G, Fattore D, Marasca C, Damiani G, Annunziata MC.
Support Care Cancer. 2020 Jun 8. doi: 10.1007/s00520-020-05563-1. [Epub ahead of print]. Survey / cross-sectional study.

Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic.
Earnshaw CH, Hunter HJA, McMullen E, Griffiths CEM, Warren RB.
Br J Dermatol. 2020 Jun 4. doi: 10.1111/bjd.19267. [Epub ahead of print]. Research study / audit.

Melanoma defies 'lockdown': ongoing detection during Covid-19 in central London.
Schauer AA, Kulakov EL, Martyn-Simmons CL, Bunker CB, Edmonds E.
Clin Exp Dermatol. 2020 Jun 5. doi: 10.1111/ced.14324. [Epub ahead of print]. Case series / audit.

Increasing melanoma awareness amongst health and social care professionals in secondary care in an era of reduced skin cancer referrals.
Quinlan C, Gill R, Murphy M.
Clin Exp Dermatol. 2020 Jun 2. doi: 10.1111/ced.14323. [Epub ahead of print]. Survey.

Virtual melanoma checks during a pandemic.
Janda M, Swetter SM, Horsham C, Soyer HP.
Br J Dermatol. 2020 May 29. doi: 10.1111/bjd.19255. [Epub ahead of print]. Commentary / recommendations.

Melanoma screening days during the coronavirus disease 2019 (COVID-19) pandemic: Strategies to adopt.
Villani A, Fabbrocini G, Costa C, Scalvenzi M.
Dermatol Ther (Heidelb). 2020 May 28. doi: 10.1007/s13555-020-00402-x. [Epub ahead of print]. Commentary / recommendations.

Hypofractionated radiotherapy in patients with non-melanoma skin cancer in the post COVID-19 era: Time to reconsider its role for most patients.
Veness M.
J Med Imaging Radiat Oncol. 2020 May 27. doi: 10.1111/1754-9485.13070. [Epub ahead of print]. Commentary.

COVID-19 in a melanoma patient under treatment with checkpoint-inhibition.
Schmidle P, Biedermann T, Posch C.
J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16661. [Epub ahead of print]. Case report.

COVID-19 and dermatology: A comprehensive guide for dermatologists.
Fahmy DH, El-Amawy HS, El-Samongy MA, Foud AA, Soliman SH, El-Kady A, Farnetani F, Conti A, Zoeir A, Eissa A, Eissa R, Puliatti S, Sighinolfi MC, Rocco B, Pellacani G.
J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16545. [Epub ahead of print]. Review / commentary.

Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.
Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Agostini A, Tonella L, Ribero S, Fierro MT.
J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16586. [Epub ahead of print]. Commentary.

Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
Yekedüz E, Dursun B, Aydın GÇ, Yazgan SC, Öztürk HH, Azap A, Utkan G, Ürün Y.
J Oncol Pharm Pract. 2020 May 19:1078155220924084. doi: 10.1177/1078155220924084. [Epub ahead of print]. Case report.

Radiotherapy and systemic treatment for non-melanoma skin cancer in the COVID-19 pandemic.
Rembielak A, Sykes AJ, Fife K, Challapalli A, Nobes JP.
Clin Oncol (R Coll Radiol). 2020 May 7. pii: S0936-6555(20)30194-1. doi: 10.1016/j.clon.2020.04.014. [Epub ahead of print] No abstract available. Editorial / recommendations.

Considerations for management of longitudinal melanonychia during the COVID-19 pandemic: An international perspective.
Lipner SR, Iorizzo M, Jellinek N, Piraccini BM, Scher RK.
J Am Acad Dermatol. 2020 May 13. doi: 10.1016/j.jaad.2020.05.028. [Epub ahead of print] No abstract available. Commentary / management recommendations.

Perspectives on the recommendations for skin cancer management during the COVID-19 pandemic.
Geskin LJ, Trager MH, Aasi SZ, Bickers DR, Carvajal RD, Nghiem P, Taback B, Zeitouni NC, Samie FH.
J Am Acad Dermatol. 2020 May 6. pii: S0190-9622(20)30821-5. doi: 10.1016/j.jaad.2020.05.002. [Epub ahead of print] No abstract available. Editorial / commentary.

Struggling with COVID: Every cancer patient is unique, and needs their own plan.
Alam M.
J Am Acad Dermatol. 2020 May 6. pii: S0190-9622(20)30820-3. doi: 10.1016/j.jaad.2020.04.166. [Epub ahead of print] No abstract available. Commentary.

Covid infection and sentinel lymph node procedure for melanoma: management in a dermo-oncology centre in a high-risk pandemic area.
Caliendo V, Picciotto F, Quaglino P, Ribero S.
Dermatol Ther. 2020 May 8. doi: 10.1111/dth.13536. [Epub ahead of print] No abstract available. Report / commentary.

Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model.
Tejera-Vaquerizo A, Nagore E.
J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16555. [Epub ahead of print]. Letter / model.

Skin cancer plastic surgery during the COVID-19 pandemic.
Gentileschi S, Caretto AA, Tagliaferri L, Salgarello M, Peris K.
Eur J Surg Oncol. 2020 May 1. pii: S0748-7983(20)30445-5. doi: 10.1016/j.ejso.2020.04.048. [Epub ahead of print] No abstract available. Commentary.

The danger of neglecting melanoma during the COVID-19 pandemic.
Gomolin T, Cline A, Handler MZ.
J Dermatolog Treat. 2020 Apr 29:1-8. doi: 10.1080/09546634.2020.1762844. [Epub ahead of print]. Commentary.

Skin cancer triage and management during COVID-19 pandemic.
Tagliaferri L, Di Stefani A, Schinzari G, Fionda B, Rossi E, Del Regno L, Gentileschi S, Federico F, Valentini V, Tortora G, Peris K; Gemelli Skin-Cancer Multidisciplianry Tumour Board (S-MDTB).
J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16529. [Epub ahead of print]. Commentary.

Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment.
Villani A, Fabbrocini G, Costa C, Scalvenzi M.
J Am Acad Dermatol. 2020 Mar 31. pii: S0190-9622(20)30479-5. doi: 10.1016/j.jaad.2020.03.057. [Epub ahead of print] No abstract available.

Management of advanced melanoma in the COVID-19 era.
Conforti C, Giuffrida R, Di Meo N, Zalaudek I.
Dermatol Ther. 2020 Apr 22:eacronym. doi: 10.1111/dth.13444. [Epub ahead of print] No abstract available.

Hidradenitis suppurativa

Impact of treatment with TNF-α inhibitors for hidradenitis suppurativa during the COVID-19 pandemic.
Benesh G, Andriano TM, Babbush KM, Hosgood HD, Cohen SR.
J Cutan Med Surg. 2021 Feb 24:1203475421997058. doi: 10.1177/1203475421997058. Online ahead of print. Cross-sectional study.

Hidradenitis suppurativa and adalimumab in the COVID-19 era.
Marzano AV, Moltrasio C, Genovese G, Muratori S, Dapavo P, Fabbrocini G, Patrizi A, Sechi A, Micali G, Pellegrino M, Gisondi P, Dini V, Bianchi L, Fania L, Offidani A, Prignano F, Atzori L, Miraglia E, Cannavò SP, Bettoli V, Stingeni L, Balestri R, Venturini M, Peris K.
Eur J Dermatol. 2020 Dec 18. doi: 10.1684/ejd.2020.3927. Online ahead of print. Report.

Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak. A review of the literature.
Marasca C, Fabbrocini G, Barrea L, Capasso G, Di Guida A, Cinelli E, Fontanella G.
Minerva Endocrinol. 2020 Sep 24. doi: 10.23736/S0391-1977.20.03248-4. Online ahead of print. Review.

COVID-19 occurrence in one secukinumab-treated patient affected by hidradenitis suppurativa and systemic lupus erythematosus.
Chiricozzi A, Garcovich S, Malvaso D, Giovanardi G, Peris K.
Int J Dermatol. 2020 Sep 23. doi: 10.1111/ijd.15209. Online ahead of print. Case report.

COVID-19 in hidradenitis suppurativa patients.
Lima XT, Cueva MA, Alora MB.
Br J Dermatol. 2020 Aug 16. doi: 10.1111/bjd.19492. Online ahead of print. Retrospective cohort study.

Management of patients with hidradenitis suppurativa during the Covid-19 pandemic: risk and benefit of immunomodulatory therapy.
Molinelli E, Diotallevi F, Simonetti O, Brisigotti V, Sapigni C, Radi G, Campanati A, Offidani A.
Dermatol Ther. 2020 Aug 29. doi: 10.1111/dth.14256. Online ahead of print. Commentary.

Biologic drugs during COVID-19 outbreak.
Montesu MA, Biondi G, Sotgiu G, Sucato F, Satta R.
Int J Dermatol. 2020 Aug 6. doi: 10.1111/ijd.15088. Online ahead of print. Cohort study.

Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic.
Kearns DG, Chat VS, Uppal S, Wu JJ.
J Am Acad Dermatol. 2020 Jul 28:S0190-9622(20)32287-8. doi: 10.1016/j.jaad.2020.07.086. Online ahead of print. Trial analysis / commentary.

Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas.
Okeke CAV, Shipman WD, Perry JD, Kerns ML, Okoye GA, Byrd AS.
J Dermatolog Treat. 2020 Jul 9:1-2. doi: 10.1080/09546634.2020.1781042. [Epub ahead of print] No abstract available. Commentary.

Global Hidradenitis Suppurativa COVID-19 Registry: A registry to inform data-driven management practices.
Naik HB, Alhusayen R, Frew J, Guilbault S, Ingram JR, Lowes MA, Marzano AV, Paul M, Villumsen B, Yannuzzi CA.
Br J Dermatol. 2020 Jun 29. doi: 10.1111/bjd.19345. [Epub ahead of print]. Research letter.

Experience in patients with hidradenitis suppurativa and COVID-19 symptoms.
Galán Sánchez JL, San Nicasio CS, Olivares MG, Martín CG, Madueño KD, Martín Díaz MÁ, Tarjuelo DV, Dobao PC.
J Am Acad Dermatol. 2020 Jun 27. pii: S0190-9622(20)32086-7. doi: 10.1016/j.jaad.2020.06.986. [Epub ahead of print]. Case series.

Remote management of hidradenitis suppurativa in a pandemic era of COVID-19.
Kang NC, Hsiao J, Shi V, Naik HB, Lowes MA, Alavi A.
Int J Dermatol. 2020 Jun 23. doi: 10.1111/ijd.15022. [Epub ahead of print] No abstract available. Review / commentary.

Management of patients with hidradenitis suppurativa during the COVID-19 pandemic.
Montero-Vilchez T, Martinez-Lopez A, Salvador-Rodriguez L, Molina-Leyva A, Arias-Santiago S.
Dermatol Ther. 2020 Jun 19:e13875. doi: 10.1111/dth.13875. [Epub ahead of print] No abstract available. Commentary.

Moderate to severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak.
Giulia R, Alice R, Teresa FM, Paolo D, Simone R.
Dermatol Ther. 2020 May 24. doi: 10.1111/dth.13680. [Epub ahead of print] No abstract available. Retrospective cohort study.

Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
Rosi E, Pimpinelli N, Prignano F.
J Dermatolog Treat. 2020 May 20:1-4. doi: 10.1080/09546634.2020.1771256. [Epub ahead of print] No abstract available. Letter / commentary.

Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral centre of Southern Italy.
Marasca C, Ruggiero A, Megna M, Annunziata MC, Fabbrocini G.
J Dermatolog Treat. 2020 May 13:1-3. doi: 10.1080/09546634.2020.1769828. [Epub ahead of print] No abstract available.

Exploring the risk of severe COVID-19 infection in hidradenitis suppurativa patients.
Seltzer JA, Okeke CAV, Perry JD, Shipman WD, Okoye GA, Byrd AS.
J Am Acad Dermatol. 2020 May 7. pii: S0190-9622(20)30839-2. doi: 10.1016/j.jaad.2020.05.012. [Epub ahead of print] No abstract available. Commentary.

Dermatology patients' knowledge and concerns regarding their immunomodulatory medication during the COVID-19 pandemic.
Keeling E, Daly S, McKenna DB.
Dermatol Ther. 2020 May 1:e13488. doi: 10.1111/dth.13488. [Epub ahead of print] No abstract available. Survey.

Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic.
Shah M, Naik HB, Alhusayen R.
J Am Acad Dermatol. 2020 Apr 30. pii: S0190-9622(20)30763-5. doi: 10.1016/j.jaad.2020.04.142. [Epub ahead of print] No abstract available. Commentary.

The role of virtual support groups for patients with hidradenitis suppurativa during the COVID-19 pandemic.
Stout M.
Int J Womens Dermatol. 2020 Apr 29. doi: 10.1016/j.ijwd.2020.04.009. [Epub ahead of print] No abstract available. Report / commentary.

Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations.
Blaszczak A, Trinidad JCL, Cartron AM.
J Am Acad Dermatol. 2020 Apr 10. pii: S0190-9622(20)30606-X. doi: 10.1016/j.jaad.2020.04.030. [Epub ahead of print] No abstract available.

Managing cutaneous immune-mediated diseases during the COVID-19 pandemic.
Torres T, Puig L.
Am J Clin Dermatol. 2020 Apr 10. doi: 10.1007/s40257-020-00514-2. [Epub ahead of print]

Bullous diseases

The risk of Coronavirus disease 2019 (COVID-19) in patients with bullous pemphigoid and pemphigus: A population-based cohort study.
Kridin K, Schonmann Y, Weinstein O, Schmidt E, Ludwig RJ, Cohen AD.
J Am Acad Dermatol. 2021 Mar 17:S0190-9622(21)00589-2. doi: 10.1016/j.jaad.2021.02.087. Online ahead of print. Case-control / cohort study.

Comment on "An Evidence-Based Guide to SARS-Cov-2 Vaccination of Patients on Immunotherapies in Dermatology.".
Speeckaert R, Lambert J, Puig L, Speeckaert M, Lapeere H, De Schepper S, van Geel N.
J Am Acad Dermatol. 2021 Mar 17:S0190-9622(21)00584-3. doi: 10.1016/j.jaad.2021.03.038. Online ahead of print. Commentary.

COVID-19 pandemic and autoimmune bullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation.
Kasperkiewicz M, Yale M, Strong R, Zillikens D, Woodley DT, Recke A.
J Eur Acad Dermatol Venereol. 2021 Mar 16. doi: 10.1111/jdv.17228. Online ahead of print. Cross-sectional study.

Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.
Kasperkiewicz M, Schmidt E, Amagai M, Fairley JA, Joly P, Murrell DF, Payne AS, Yale ML, Zillikens D, Woodley DT.
J Eur Acad Dermatol Venereol. 2021 Mar 2. doi: 10.1111/jdv.17207. Online ahead of print. Review & recommendations.

Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris.
Jafri ZA, Walia S, Ivanic MG, Wu JJ.
J Dermatolog Treat. 2020 Dec 29:1-6. doi: 10.1080/09546634.2020.1870648. Online ahead of print. Review.

Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: a retrospective cohort study.
Mahmoudi H, Farid AS, Nili A, Dayani D, Tavakolpour S, Soori T, Teimourpour A, Isazade A, Abedini R, Balighi K, Daneshpazhooh M; Autoimmune Bullous Diseases Research Group.
J Am Acad Dermatol. 2020 Dec 22:S0190-9622(20)33237-0. doi: 10.1016/j.jaad.2020.12.043. Online ahead of print. Retrospective cohort study.

Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases.
Pawar M, Singh M.
Clin Dermatol. 2020 Nov-Dec;38(6):750-756. doi: 10.1016/j.clindermatol.2020.06.006. Epub 2020 Jun 19. Review / commentary.

Can rituximab be used in the treatment of pemphigus vulgaris during the COVID-19 pandemic?
Uzuncakmak TK, Özkoca D, Askin O, Kutlubay Z.
Dermatol Ther. 2020 Dec 9:e14647. doi: 10.1111/dth.14647. Online ahead of print. Case series.

Management of a case of pemphigus foliaceus in a paraplegic man with palliative dermatology principles during COVID-19 pandemic.
Hafi B, Uvais NA, Jafferany M, Razmi T M, Tp A, Ameerali AM.
Dermatol Ther. 2020 Nov 20. doi: 10.1111/dth.14564. Online ahead of print. Case report.

Letter in reply: Toward a COVID-19 vaccine strategy for pemphigus patients on rituximab.
Waldman RA, Creed M, Sharp K, Adalsteinnson J, Imitola J, Durso T, Lu J.
J Am Acad Dermatol. 2020 Oct 29:S0190-9622(20)32896-6. doi: 10.1016/j.jaad.2020.10.075. Online ahead of print. Commentary.

Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.
Beyzaee AM, Rahmatpour Rokni G, Patil A, Goldust M.
Dermatol Ther. 2020 Oct 13. doi: 10.1111/dth.14405. Online ahead of print. Review.

Aggressive course of pemphigus vulgaris following COVID-19 infection.
Ghalamkarpour F, Pourani MR.
Dermatol Ther. 2020 Oct 10:e14398. doi: 10.1111/dth.14398. Online ahead of print. Case report.

Immunobullous diseases, prothrombotic state, and COVID-19: Role of prophylactic anticoagulation in bullous pemphigoid and pemphigus.
Anuragi RP, Kansal NK.
Dermatol Ther. 2020 Oct 1:e14361. doi: 10.1111/dth.14361. Online ahead of print. Commentary.

Reply to "Treatment considerations for patients with pemphigus during the COVID-19 pandemic".
Schultz B, Pearson DR, Mansh M.
J Am Acad Dermatol. 2020 Sep 4:S0190-9622(20)32581-0. doi: 10.1016/j.jaad.2020.07.132. Online ahead of print. Commentary.

Authors' Reply to the comment 'Treatment considerations for patients with pemphigus during the COVID-19 pandemic'.
Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS.
J Am Acad Dermatol. 2020 Sep 4:S0190-9622(20)32582-2. doi: 10.1016/j.jaad.2020.09.002. Online ahead of print. Commentary.

Pemphigus and COVID-19: Critical overview of management with a focus on treatment choice.
Elmas ÖF, Demirbaş A, Türsen Ü, Atasoy M, Lotti T.
Dermatol Ther. 2020 Sep 3:e14265. doi: 10.1111/dth.14265. Online ahead of print. Review.

Use of immunosuppressants/immunomodulators in autoimmune/inflammatory dermatologic diseases during COVID-19 pandemic - General recommendation based on available evidence.
De D, Pandhi D.
Indian Dermatol Online J. 2020 Jul 13;11(4):526-533. doi: 10.4103/idoj.IDOJ_414_20. eCollection 2020 Jul-Aug. Review / recommendations.

Treatment of pemphigus patients in the COVID-19 era: a specific focus on rituximab.
Mahmoudi H, Tavakolpour S, Nili A, Salehi Farid A, Daneshpazhooh M, Rashidian M.
Dermatol Ther. 2020 Aug 14:e14188. doi: 10.1111/dth.14188. Online ahead of print. Commentary.

Novel coronavirus 2019 (COVID-19) and epidermolysis bullosa: report of three cases.
Abdollahimajd F, Youssefian L, Pourani MR, Vahidnezhad H, Uitto J.
Dermatol Ther. 2020 Aug 14:e14194. doi: 10.1111/dth.14194. Online ahead of print. Case reports.

COVID-19 outbreak and autoimmune bullous diseases: A systematic review of published cases.
Kasperkiewicz M.
J Am Acad Dermatol. 2020 Aug 8:S0190-9622(20)32366-5. doi: 10.1016/j.jaad.2020.08.012. Online ahead of print. Systematic review.

Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center.
Diotallevi F, Simonetti O, Radi G, Campanati A, Brisigotti V, Tagliati C, Rizzetto G, Martina E, Offidani A.
Australas J Dermatol. 2020 Aug 5. doi: 10.1111/ajd.13414. Online ahead of print. Report / audit.

Treatment of severe pemphigus vulgaris during COVID-19 pandemic.
Pathania YS, Bhardwaj A.
J Dermatolog Treat. 2020 Jul 29:1-4. doi: 10.1080/09546634.2020.1801971. Online ahead of print. Commentary / recommendations.

Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era.
Azimi SZ, Firooz A, Murrell DF, Daneshpazhooh M.
Dermatol Ther. 2020 Jul 4:e13956. doi: 10.1111/dth.13956. [Epub ahead of print]. Review.

COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: A tele-medicine experience.
Shahidi-Dadras M, Abdollahimajd F, Ohadi L, Tabary M, Araghi F, Mozafari N, Toosi P, Dadkhahfar S.
J Dermatolog Treat. 2020 Jun 27:1-7. doi: 10.1080/09546634.2020.1789041. [Epub ahead of print]. Cross-sectional study.

Epidermolysis bullosa and the COVID-19 pandemic: challenges and recommendations.
Vahidnezhad H, Moravvej H, Bahmanjahromi A, Youssefian L, Abdollahimajd F.
J Dermatolog Treat. 2020 Jun 26:1-6. doi: 10.1080/09546634.2020.1788701. [Epub ahead of print] No abstract available. Commentary & recommendations.

Patients with specific skin disorders who are affected by COVID-19: what do experiences say about management strategies? : A systematic review.
Najar Nobar N, Goodarzi A.
Dermatol Ther. 2020 Jun 18:e13867. doi: 10.1111/dth.13867. [Epub ahead of print]. Systematic review.

Bullous skin disease patients in a high-epidemic COVID-19 area, Bergamo, Italy.
Carugno A, Sena P, Raponi F, Robustelli Test E, Vezzoli P.
Br J Dermatol. 2020 Jun 1. doi: 10.1111/bjd.19266. [Epub ahead of print]. Case series.

Patients with bullous disorders during COVID-19 period: management and adherence to treatment.
De Fata Salvatores G, Villani A, Fabbrocini G, Di Guida A.
Dermatol Ther. 2020 May 26:e13697. doi: 10.1111/dth.13697. [Epub ahead of print] No abstract available. Report / audit.

Management of pemphigus in COVID-19 pandemic era; a review article.
Abdollahimajd F, Shahidi-Dadras M, M Robati R, Dadkhahfar S.
Arch Acad Emerg Med . 2020 Apr 18;8(1):e51. eCollection 2020. Review.

Management strategies of autoimmune bullous diseases during the outbreak of 2019 novel coronavirus disease (COVID-19).
Chen P, Zhang G, Zhan Y.
J Dermatolog Treat. 2020 May 18:1-7. doi: 10.1080/09546634.2020.1771261. [Epub ahead of print]. Recommendations / commentary.

Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case-report.
Daneshpazhooh M, Soori T, Isazade A, Noormohammadpour P.
J Dermatolog Treat. 2020 May 2:1-6. doi: 10.1080/09546634.2020.1764472. [Epub ahead of print] No abstract available. Case report.

Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus.
Balestri R, Rech G, Girardelli CR.
J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16578. [Epub ahead of print]. Case report / commentary.

Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
Di Altobrando A, Patrizi A, Bardazzi F.
J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16491. [Epub ahead of print]

Treatment considerations for patients with pemphigus during the COVID-19 pandemic.
Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS.
J Am Acad Dermatol. 2020 Apr 10. pii: S0190-9622(20)30544-2. doi: 10.1016/j.jaad.2020.04.005. [Epub ahead of print] No abstract available.

Paediatric

Cutaneous findings in SARS-CoV-2-associated multisystem inflammatory disease in children.
Blatz AM, Oboite M, Chiotos K, Castelo-Soccio L, Odom John AR; Children’s Hospital of Philadelphia MIS-C Research Collaborative.
Open Forum Infect Dis. 2021 Feb 16;8(3):ofab074. doi: 10.1093/ofid/ofab074. eCollection 2021 Mar. Case series.

Non-specific oral and cutaneous manifestations of Coronavirus Disease 2019 in children.
Bardellini E, Bondioni MP, Amadori F, Veneri F, Lougaris V, Meini A, Plebani A, Majorana A.
Med Oral Patol Oral Cir Bucal. 2021 Mar 27:24461. doi: 10.4317/medoral.24461. Online ahead of print. Retrospective cross-sectional study.

Acral changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA).
Castelo-Soccio L, Lara-Corrales I, Paller AS, Bean E, Rangu S, Oboite M, Flohr C, Ahmad RC, Calberg V, Gilliam A, Pope E, Reynolds S, Sibbald C, Shin HT, Berger E, Schaffer J, Siegel MP, Cordoro KM.
Pediatr Dermatol. 2021 Mar 20. doi: 10.1111/pde.14566. Online ahead of print.

A response to ''Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children''.
Sert A.
J Am Acad Dermatol. 2021 Mar 4:S0190-9622(21)00487-4. doi: 10.1016/j.jaad.2021.02.076. Online ahead of print. Commentary.

Gianotti-crosti syndrome in the setting of recent coronavirus disease-19 infection.
Swali RN, Lee EB, Adams JL.
Pediatr Dermatol. 2021 Feb 28. doi: 10.1111/pde.14518. Online ahead of print. Case report.

Impact of the COVID-19 pandemic on children with psoriasis.
Beytout Q, Pepiot J, Maruani A, Devulder D, Aubert R, Beylot-Barry M, Amici JM, Jullien D, Mahé E; Association France Psoriasis; Research Group on Psoriasis of the French Society of Dermatology (GrPso); Research Group of the French Society of Pediatric Dermatology (SFPD).
Ann Dermatol Venereol. 2021 Feb 23:S0151-9638(21)00027-2. doi: 10.1016/j.annder.2021.01.005. Online ahead of print. Survey.

Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children: a review of 47 pediatric patients.
Halepas S, Lee KC, Myers A, Yoon RK, Chung W, Peters SM.
J Am Dent Assoc. 2021 Mar;152(3):202-208. doi: 10.1016/j.adaj.2020.11.014. Epub 2020 Dec 9. Case series / retrospective case review.

Cutaneous manifestations related to COVID-19 immune dysregulation in the pediatric age group.
Larenas-Linnemann D, Luna-Pech J, Navarrete-Rodríguez EM, Rodríguez-Pérez N, Arias-Cruz A, Blandón-Vijil MV, Del Rio-Navarro BE, Estrada-Cardona A, Onuma-Takane E, Pozo-Beltrán CF, Valencia-Herrera AM, Ortiz-Aldana FI, Toledo-Bahena ME.
Curr Allergy Asthma Rep. 2021 Feb 25;21(2):13. doi: 10.1007/s11882-020-00986-6. Review.

Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis.
Toraih EA, Hussein MH, Elshazli RM, Kline A, Munshi R, Sultana N, Taghavi S, Killackey M, Duchesne J, Fawzy MS, Kandil E.
World J Pediatr. 2021 Feb 20. doi: 10.1007/s12519-021-00419-y. Online ahead of print. Systematic review.

Evaluation of cutaneous symptoms in children infected with COVID-19.
Metbulut AP, Ozkaya Parlakay A, Bayhan Gİ, Kanik S, Gülhan B, Şengül Emeksiz Z, Şenel E, Dibek Misirlioglu E.
Pediatr Allergy Immunol. 2021 Feb 8. doi: 10.1111/pai.13467. Online ahead of print. Prospective cohort study.

Different hair loss patterns in two pediatric patients with COVID-19 associated multisystem inflammatory syndrome in children (MIS-C).
Hayran Y, Yorulmaz A, Gür G, Aktaş A.
Dermatol Ther. 2021 Jan 28. doi: 10.1111/dth.14820. Online ahead of print. Case reports.

A child with Henoch-Schonlein purpura secondary to a COVID-19 infection.
AlGhoozi DA, AlKhayyat HM.
BMJ Case Rep. 2021 Jan 6;14(1):e239910. doi: 10.1136/bcr-2020-239910. Case report.

Acute urticaria preceding other COVID-19-associated manifestations-A case report.
Chen V, Escandon Brehm J, Bellodi Schmidt F.
Pediatr Dermatol. 2021 Jan 7. doi: 10.1111/pde.14505. Online ahead of print. Case report.

COVID-19 infection presenting with cheilitis and fever in a toddler.
Christian NA, Wadhawan J, Abdelmalek S, Pierre L, Adeyinka A.
Cureus. 2021 Jan 3;13(1):e12444. doi: 10.7759/cureus.12444. Case report.

Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and MIS-C.
Rekhtman S, Tannenbaum R, Strunk A, Birabaharan M, Wright S, Garg A.
J Am Acad Dermatol. 2020 Oct 24:S0190-9622(20)32872-3. doi: 10.1016/j.jaad.2020.10.060. Online ahead of print. Cohort study.

Mucocutaneous manifestations of multisystem inflammatory syndrome in children during the COVID-19 pandemic.
Young TK, Shaw KS, Shah JK, Noor A, Alperin RA, Ratner AJ, Orlow SJ, Betensky RA, Shust GF, Kahn PJ, Oza VS.
JAMA Dermatol. 2020 Dec 9. doi: 10.1001/jamadermatol.2020.4779. Online ahead of print. Case series.

Skin manifestations during the COVID-19 pandemic in the pediatric emergency department.
Oliva Rodríguez-Pastor S, Martín Pedraz L, Carazo Gallego B, Galindo Zavala R, Lozano Sánchez G, de Toro Pseinado I, Rodriguez Benjumea M, Mejias A, Cuadros EN.
Pediatr Int. 2020 Dec 5. doi: 10.1111/ped.14568. Online ahead of print. Prospective cohort study.

Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C.
Mazori DR, Derrick KM, Kapoor U, Haribhai M, Gist RE, Glick SA.
Pediatr Dermatol. 2020 Nov 22. doi: 10.1111/pde.14462. Online ahead of print. Case reports.

Kawasaki disease-like features in 10 pediatric COVID-19 cases: A retrospective study.
Falah NU, Hashmi S, Ahmed Z, Jaan A, Akhtar A, Khalid F, Farooque U, Shera MT, Ali S, Javed A.
Cureus. 2020 Oct 19;12(10):e11035. doi: 10.7759/cureus.11035. Case series.

Cutaneous and histopathological features of Coronavirus disease 2019 in pediatrics: A review article.
Khalili M, Iranmanesh B, Mohammadi S, Aflatoonian M.
Dermatol Ther. 2020 Nov 18. doi: 10.1111/dth.14554. Online ahead of print. Review.

Skin manifestations of COVID-19 in children: Part 3.
Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertita L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A; ESPD Group for the Skin Manifestations of COVID-19.
Clin Exp Dermatol. 2020 Nov 18. doi: 10.1111/ced.14483. Online ahead of print. Review.

Skin manifestations of COVID-19 in children: Part 1.
Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertita L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A; ESPD Group for the Skin Manifestations of COVID-19.
Clin Exp Dermatol. 2020 Nov 12. doi: 10.1111/ced.14481. Online ahead of print. Review.

Skin manifestations of COVID-19 in children: Part 2.
Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertita L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A; ESPD Group for the Skin Manifestations of COVID-19.
Clin Exp Dermatol. 2020 Nov 9. doi: 10.1111/ced.14482. Online ahead of print. Review.

Atypical case of COVID-19 associated Kawasaki disease in an eight-year-old Pakistani boy.
Khan I, Sarwar A, Ahmed Z.
Cureus. 2020 Sep 26;12(9):e10670. doi: 10.7759/cureus.10670. Case report.

Giant urticaria and acral peeling in a child with COVID-19.
Rotulo GA, Signa S, Rosina S, Pastorino C, Bondi E, Maghnie M.
J Pediatr. 2020 Oct 21:S0022-3476(20)31311-1. doi: 10.1016/j.jpeds.2020.10.039. Online ahead of print.

An outbreak of acute hemorrhagic papules on the posterior neck in children during the COVID-19 pandemic.
Smith A, Polcari I, Maguiness S, Boull C.
Pediatr Dermatol. 2020 Sep 6. doi: 10.1111/pde.14325. Online ahead of print. Case series.

COVID-19 inflammatory syndrome with clinical features resembling Kawasaki disease.
Spencer R, Closson RC, Gorelik M, Boneparth AD, Hough RF, Acker KP, Krishnan U.
Pediatrics. 2020 Aug 25:e20201845. doi: 10.1542/peds.2020-1845. Online ahead of print. Case reports.

Fever with rash is one of the first presentations of COVID-19 in children: A case report.
Navaeifar MR, Poudineh Ghazaghi M, Shahbaznejad L, Rouhanizadeh H, Abutalebi M, Ranjbar Varandi M, Rezai MS.
Int Med Case Rep J. 2020 Aug 7;13:335-340. doi: 10.2147/IMCRJ.S262935. eCollection 2020. Case report.

A case of COVID-19 with late-onset rash and transient loss of taste and smell in a 15-year-old boy.
Maniaci A, Iannella G, Vicini C, Pavone P, Nunnari G, Falsaperla R, Di Mauro P, Ferlito S, Cocuzza S.
Am J Case Rep. 2020 Aug 20;21:e925813. doi: 10.12659/AJCR.925813. Case report.

COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020.
Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J, Roguski K, Wallace B, Prezzato E, Koumans EH, Lee EH, Geevarughese A, Lash MK, Reilly KH, Pulver WP, Thomas D, Feder KA, Hsu KK, Plipat N, Richardson G, Reid H, Lim S, Schmitz A, Pierce T, Hrapcak S, Datta D, Morris SB, Clarke K, Belay E; California MIS-C Response Team.
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1074-1080. doi: 10.15585/mmwr.mm6932e2. Cross-sectional study.

Young children presenting with fever and rash in the midst of SARS-CoV-2 outbreak in New York.
Wolfe DM, Nassar GN, Divya K, Krilov LR, Noor A.
Clin Pediatr (Phila). 2020 Jul 7:9922820941631. doi: 10.1177/0009922820941631. [Epub ahead of print] No abstract available. Case reports.

At home dose escalation of propranolol for infantile hemangiomas during the COVID-19 pandemic.
Bassi A, Azzarelli A, Vaccaro A, Mazzatenta C.
Dermatol Ther. 2020 Jul 7:e13977. doi: 10.1111/dth.13977. [Epub ahead of print] No abstract available. Case series.

Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme.
Bapst T, Romano F, Müller M, Rohr M.
BMJ Case Rep. 2020 Jun 29;13(6). pii: e236986. doi: 10.1136/bcr-2020-236986. No abstract available. Case report.

Introductory histopathologic findings may shed light on COVID19 pediatric hyperinflammatory shock syndrome.
Schnapp A, Abulhija H, Maly A, Armoni-Weiss G, Levin Y, Faitatziadou SM, Molho-Pessach V.
J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16749. [Epub ahead of print]. Case report.

Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated With SARS-CoV-2.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davies P, Kucera F, Brierley J, McDougall M, Carter M, Tremoulet A, Shimizu C, Herberg J, Burns JC, Lyall H, Levin M; PIMS-TS 糖心原创 Group and EUCLIDS and PERFORM Consortia.
JAMA. 2020 Jun 8. doi: 10.1001/jama.2020.10369. [Epub ahead of print]. Case series.

Global coronavirus pandemic (SARS CoV-2): Past, present, and future of pediatric dermatology.
Simonetti O, Diotallevi F, Campanati A, Brisigotti V, Radi G, Molinelli E, Bobyr I, Martina E, Paolinelli M, Sapigni C, Offidani A.
Dermatol Ther. 2020 Jun 4:e13767. doi: 10.1111/dth.13767. [Epub ahead of print]. Report / audit.

COVID-19 and ectodermal dysplasias. Recommendations are necessary.
Callea M, Willoughby CE, Perry D, Holzer U, Fedele G, Cárdenas Tadich A, Cammarata-Scalisi F.
Dermatol Ther. 2020 May 30:e13702. doi: 10.1111/dth.13702. [Epub ahead of print] No abstract available. Commentary.

Multisystem Inflammatory Syndrome in Children during the COVID-19 pandemic: a case series.
Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, Fitzgerald JC, Topjian A, John ARO.
J Pediatric Infect Dis Soc. 2020 May 28. pii: piaa069. doi: 10.1093/jpids/piaa069. [Epub ahead of print]. Case series.

Management of infantile hemangiomas during the COVID pandemic.
Frieden IJ, Püttgen KB, Drolet BA, Garzon MC, Chamlin SL, Pope E, Mancini AJ, Lauren CT, Mathes EF, Siegel DH, Gupta D, Haggstrom AN, Tollefson MM, Baselga E, Morel KD, Shah SD, Holland KE, Adams DM, Horii KA, Newell BD, Powell J, McCuaig CC, Nopper AJ, Metry DW, Maguiness S; Hemangioma Investigator Group.
Pediatr Dermatol. 2020 Apr 16. doi: 10.1111/pde.14196. [Epub ahead of print]

COVID-19 in the pediatric population.
Abdelmaksoud A, Kroumpouzos G, Jafferany M, Lotti T, Sadoughifar R, Goldust M.
Dermatol Ther. 2020 Mar 27:e13339. doi: 10.1111/dth.13339. [Epub ahead of print] No abstract available.

Infants born to mothers with a new coronavirus (COVID-19).
Chen Y, Peng H, Wang L, Zhao Y, Zeng L, Gao H, Liu Y.
Front Pediatr. 2020 Mar 16;8:104. doi: 10.3389/fped.2020.00104. eCollection 2020.

Other conditions and groups

Extraordinary claims without extraordinary evidence controversy on anti-androgen therapy for COVID-19.
Trüeb RM, Régnier A, Caballero-Uribe N, Dias MFRG, Dutra Rezende H.
J Eur Acad Dermatol Venereol. 2021 Mar 30. doi: 10.1111/jdv.17249. Online ahead of print. Commentary.

Interest in aesthetics during COVID-19 pandemic: A Google Trends analysis.
Elsaie ML, Youssef EA.
J Cosmet Dermatol. 2021 Mar 24. doi: 10.1111/jocd.14101. Online ahead of print. Internet search analysis.

Hypersensitivity reaction to hyaluronic acid dermal filler following novel coronavirus infection - a case report.
Rowland-Warmann MJ.
J Cosmet Dermatol. 2021 Mar 18. doi: 10.1111/jocd.14074. Online ahead of print. Case report.

Cosmetic consumer preferences during COVID-19 pandemic: A new normal?
Wang JV, Munavalli GS, Zachary CB, Geronemus RG.
Dermatol Surg. 2021 Mar 9. doi: 10.1097/DSS.0000000000002969. Online ahead of print. Survey.

Association of home light therapy with patient-reported outcomes of vitiligo during the COVID-19 pandemic: an internet-based survey.
Xu Z, Jin S, Dai X, Xiang LF, Zhang C.
Photodermatol Photoimmunol Photomed. 2021 Mar 11. doi: 10.1111/phpp.12675. Online ahead of print. Survey / cross-sectional study.

Is systemic isotretinoin use a risk factor for coronavirus disease 2019 (COVID-19)?
Gundogdu M, Dere G.
J Cosmet Dermatol. 2021 Mar 8. doi: 10.1111/jocd.14044. Online ahead of print. Retrospective cohort study.

"Delayed hypersensitivity reaction to hyaluronic acid dermal filler post COVID-19 viral infection".
Shome D, Doshi K, Vadera S, Kapoor R.
J Cosmet Dermatol. 2021 Mar 8. doi: 10.1111/jocd.14046. Online ahead of print. Case report.

Oral angiotensin converting enzyme inhibitors for the treatment of delayed inflammatory reaction of dermal hyaluronic acid fillers following COVID-19 vaccination - A model for inhibition of angiotensin II-induced cutaneous inflammation.
Munavalli GG, Knutsen-Larson S, Lupo MP, Geronemus RG.
JAAD Case Rep. 2021 Mar 2. doi: 10.1016/j.jdcr.2021.02.018. Online ahead of print.

Alopecia and severity of COVID-19: a cross-sectional study in Peru.
Salazar Arenas MÁ, Muñoz Del Carpio-Toia A, Aybar Galdos J, Rodriguez-Morales AJ.
Infez Med. 2021 Mar 1;29(1):37-45. Cross-sectional study.

Telogen effluvium in the new SARS-CoV-2 era.
Ocampo-Garza SS, Vastarella M, Nappa P, Cantelli M, Fabbrocini G.
Int J Dermatol. 2021 Mar 4. doi: 10.1111/ijd.15482. Online ahead of print. Commentary.

Androgens and women: COVID-19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism.
Yale K, Elsanadi R, Ghigi A, Zheng K, Goren A, Mesinkovska NA.
Int J Dermatol. 2021 Mar 2. doi: 10.1111/ijd.15473. Online ahead of print. Cross-sectional study.

COVID-19 and human papillomavirus: Paradoxical immunity.
Demirbaş A, Eker H, Elmas ÖF, Ulutaş Demirbaş G, Atasoy M, Türsen Ü, Lotti T.
J Cosmet Dermatol. 2021 Feb 24. doi: 10.1111/jocd.14022. Online ahead of print. Case report.

Significant decrease of facial cellulitis admissions during COVID-19 lockdown in France: a multicentric comparative study.
Kün-Darbois JD, Kahn A, Khonsari RH, Gueutier A, Baldini N, Corre P, Bertin H, Provost M, Lesclous P, Ansidei CM, Majoufre C, Louvrier A, Meyer C, Ammari H, Rougeot A, Moret A, Poisbleau D, Nicot R, Marti-Flich L, Ferri J, Lutz JC, Prevost R, Kimakhe J, Poulet V, Lauwers F, Veyssiere A, Benateau H, Dang NP, Barthelemy I, Foletti JM, Chossegros C, Queiros C, Laure B, Pare A, de Boutray M.
J Stomatol Oral Maxillofac Surg. 2021 Feb 14:S2468-7855(21)00040-9. doi: 10.1016/j.jormas.2021.02.001. Online ahead of print. Multi-centre case control study.

Coronavirus vaccine considerations for the aesthetic patient.
Rice SM, Ferree SD, Kourosh AS.
Facial Plast Surg Aesthet Med. 2021 Feb 18. doi: 10.1089/fpsam.2020.0638. Online ahead of print. Commentary.

Rapidly progressive alopecia areata totalis in a Covid-19 patient, unresponsive to tofacitinib.
Ferreira SB, Dias MFRG, Berbert Ferreira R, Neves Neto AC, Trüeb RM, Lupi O.
J Eur Acad Dermatol Venereol. 2021 Feb 15. doi: 10.1111/jdv.17170. Online ahead of print.

Increase in the number of herpes zoster cases in Brazil related to the COVID-19 pandemic.
Maia CMF, Marques NP, de Lucena EHG, de Rezende LF, Martelli DRB, Martelli-Júnior H.
Int J Infect Dis. 2021 Feb 11:S1201-9712(21)00119-3. doi: 10.1016/j.ijid.2021.02.033. Online ahead of print. Database / cross-sectional study.

Italian survey for the evaluation of the effects of coronavirus disease 2019 (COVID-19) pandemic on alopecia areata recurrence.
Rinaldi F, Trink A, Giuliani G, Pinto D.
Dermatol Ther (Heidelb). 2021 Feb 12. doi: 10.1007/s13555-021-00498-9. Online ahead of print. Survey / cross-sectional study.

Impact of COVID-19 on wound care in Germany.
Schlager JG, Kendziora B, Patzak L, Kupf S, Rothenberger C, Fiocco Z, French LE, Reinholz M, Hartmann D.
Int Wound J. 2021 Feb 7. doi: 10.1111/iwj.13553. Online ahead of print. Survey.

Neurosyphilis and the Jarisch-Herxheimer reaction: A therapy concern with HIV disease.
Kapila R, Schwartz RA.
Dermatol Ther. 2021 Feb 1:e14839. doi: 10.1111/dth.14839. Online ahead of print. Commentary & case report.

Hansen's disease in the era of COVID-19: An observation on a series of six patients with co-infection.
Arora S, Bhatnagar A, Singh GK, Pal R, Bahuguna A, Das P, Verma P.
Dermatol Ther. 2021 Feb 2:e14827. doi: 10.1111/dth.14827. Online ahead of print. Case series.

The relevance of vitamin D supplementation for people of color in the era of COVID-19.
Grimes PE, Elbuluk N, Alexis AF.
J Drugs Dermatol. 2020 Jul 1;19(7):782-783. doi: 10.36849/JDD.2021.5414. Review.

PASTUL questionnaire: a tool for self-assessment of scleroderma skin during the COVID-19 pandemic.
Spierings J, Ong V, Denton CP.
Ann Rheum Dis. 2021 Jan 29:annrheumdis-2020-219775. doi: 10.1136/annrheumdis-2020-219775. Online ahead of print. Validitation study.

Clearance of longstanding treatment-resistant warts during covid-19 in a transplant recipient.
Erkayman MH, Bilen H.
Transpl Infect Dis. 2021 Jan 28:e13572. doi: 10.1111/tid.13572. Online ahead of print. Case report.

Diabetic foot disease during the COVID-19 pandemic.
Boulton AJM.
Medicina (Kaunas). 2021 Jan 22;57(2):97. doi: 10.3390/medicina57020097. Review.

Evaluation of urticaria patients before and during the period of the COVID-19 pandemic: A retrospective study.
Akca HM, Tuncer Kara K.
Dermatol Ther. 2021 Jan 23:e14800. doi: 10.1111/dth.14800. Online ahead of print. Retrospective case analysis.

Remote wound care.
Bolton L.
Wounds. 2020 Dec;32(12):350-352. Commentary.

Oral ivermectin for a scabies outbreak in a long-term-care facility: Potential value in preventing COVID-19 and associated mortality?
Bernigaud C, Guillemot D, Ahmed-Belkacem A, Grimaldi-Bensouda L, Lespine A, Berry F, Softic L, Chenost C, Do-Pham G, Giraudeau B, Fourati S, Chosidow O.
Br J Dermatol. 2021 Jan 16. doi: 10.1111/bjd.19821. Online ahead of print. Cohort study.

I fear COVID but diabetic foot (DF) is worse: a survey on patients' perception of a telemedicine service for DF during lockdown.
Iacopi E, Pieruzzi L, Goretti C, Piaggesi A.
Acta Diabetol. 2021 Jan 13. doi: 10.1007/s00592-020-01653-y. Online ahead of print. Survey / cross-sectional study.

Head lice were also affected by COVID-19: a decrease on Pediculosis infestation during lockdown in Buenos Aires.
Galassi F, Ortega-Insaurralde I, Adjemian V, Gonzalez-Audino P, Picollo MI, Toloza AC.
Parasitol Res. 2021 Jan 6. doi: 10.1007/s00436-020-07038-y. Online ahead of print. Survey / cross-sectional study.

Immunosuppressive therapies for alopecia areata during COVID-19: A cross-sectional survey study.
Flanagan KE, Pathoulas JT, Walker CJ, Pupo Wiss I, Ellison A, Mesinkovska NA, Senna MM.
Dermatol Ther. 2021 Jan 6. doi: 10.1111/dth.14762. Online ahead of print. Survey / cross-sectional study.

Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic.
Aşkın Ö, Özkoca D, Uzunçakmak Ü, Kevser T, Serdaroğlu S.
Dermatol Ther. 2021 Jan 6. doi: 10.1111/dth.14746. Online ahead of print. Cross-sectional study.

Reply to letter to the editor: "A response to 'Male balding is a major risk factor for severe COVID-19'".
Yousaf A, Kolodney MS.
J Am Acad Dermatol. 2020 Oct 24:S0190-9622(20)32864-4. doi: 10.1016/j.jaad.2020.10.052. Online ahead of print. Commentary.

SARS-CoV-2 not found in pressure injury exudates from COVID-19 patients.
Yu N, Zhang Y, Xiao M, Cao W, Zhang Y, Yang Y, Liu Z, Li Y, Long X, Liu Z, Zhang S, Wang X.
J Cosmet Dermatol. 2020 Dec 21. doi: 10.1111/jocd.13887. Online ahead of print. Case series.

A response to "Male balding is a major risk factor for severe COVID-19".
Thatiparthi A, Liu J, Martin A, Wu JJ.
J Am Acad Dermatol. 2020 Oct 24:S0190-9622(20)32863-2. doi: 10.1016/j.jaad.2020.10.051. Online ahead of print. Commentary.

Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak.
Pi Z, Chen P, Zhan Y, Xiao R.
Clin Dermatol. 2020 Nov-Dec;38(6):731-733. doi: 10.1016/j.clindermatol.2020.08.004. Epub 2020 Aug 5. Survey.

COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases.
Ayhan E, Öztürk M, An İ, Bekçİbaşi M.
Int J Dermatol. 2020 Dec 17. doi: 10.1111/ijd.15379. Online ahead of print. Case reports.

Isotretinoin in acne treatment during the coronavirus disease 2019 (COVID-19): a retrospective analysis of adherence to therapy and side effects.
Donnarumma M, Nocerino M, Lauro W, Annunziata MC, Marasca C, Fabbrocini G.
Dermatol Ther. 2020 Dec 15:e14677. doi: 10.1111/dth.14677. Online ahead of print. Retrospective cohort study.

Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster.
Goren A, Cadegiani FA, Wambier CG, Vano-Galvan S, Tosti A, Shapiro J, Mesinkovska NA, Ramos PM, Sinclair R, Lupi O, Hercogova J, McCoy J.
Med Hypotheses. 2020 Nov 28:110439. doi: 10.1016/j.mehy.2020.110439. Online ahead of print. Commentary.

The impact of COVID-19 pandemic on the management of patients with chronic urticaria: an observational two-center study from Turkey.
Erdem Y, Polat Ekinci A, Altunay IK, Sivaz O, Inal S, Gokalp MO, Pehlivan G, Özkaya E.
Dermatol Ther. 2020 Dec 10. doi: 10.1111/dth.14652. Online ahead of print. Cohort study.

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria.
Kocatürk E, Salman A, Cherrez-Ojeda I, et al.
Allergy. 2020 Dec 7. doi: 10.1111/all.14687. Online ahead of print. International cross-sectional study.

Cross-sectional survey examining skin picking and hair pulling disorders during the COVID-19 pandemic.
Pathoulas JT, Olson SJ, Idnani A, Farah RS, Hordinsky MK, Widge A.
J Am Acad Dermatol. 2020 Nov 27:S0190-9622(20)33038-3. doi: 10.1016/j.jaad.2020.11.011. Online ahead of print. Survey / cross-sectional study.

The risk for severe COVID 19 in patients with autoimmune and/or inflammatory diseases: First wave lessons.
Druyan A, Lidar M, Brodavka M, Levy I, Barzilai A, Pavlotsky F.
Dermatol Ther. 2020 Dec 5. doi: 10.1111/dth.14627. Online ahead of print. Cross-sectional study / retrospective chart review.
https://doi.org/10.1111/dth.14627

Effect of the Covid-19 pandemic on the anxiety and depression levels in patients who applied to the cosmetology unit.
Temiz SA, Durmaz K, Dursun R, Ataseven A, Işık B, Karaağaç O, Özer İ, Daye M.
Dermatol Ther. 2020 Dec 3:e14625. doi: 10.1111/dth.14625. Online ahead of print. Case-control study.

Impact of COVID-19 pandemic on the continuity of care for dermatologic patients on systemic therapy during the period of strict lockdown.
Alshiyab DM, Al-Qarqaz FA, Muhaidat JM.
Ann Med Surg (Lond). 2020 Dec;60:571-574. doi: 10.1016/j.amsu.2020.11.056. Epub 2020 Nov 25. Cross-sectional & cohort study.

SARS-CoV-2-induced telogen effluvium: a multicentric study.
Moreno-Arrones OM, Lobato-Berezo A, Gomez-Zubiaur A, Arias-Santiago S, Saceda-Corralo D, Bernardez-Guerra C, Grimalt R, Fernandez-Crehuet P, Ferrando J, Gil R, Hermosa-Gelbard A, Rodrigues-Barata R, Fernandez-Nieto D, Merlos-Navarro S, Vañó-Galván S.
J Eur Acad Dermatol Venereol. 2020 Nov 21. doi: 10.1111/jdv.17045. Online ahead of print. Prospective cohort study.

Hydroxychloroquine use and COVID-19 concerns among alopecia patients: A cross-sectional survey study.
Pathoulas JT, Flanagan KE, Walker CJ, Pupo Wiss I, Hagigeorges D, Senna MM.
Dermatol Ther. 2020 Nov 11. doi: 10.1111/dth.14529. Online ahead of print. Survey / cross-sectional study.

Treatment considerations for Behçet's disease in the era of COVID-19: a narrative review.
Elmas ÖF, Demirbaş A, Bağcıer F, Türsen Ü, Atasoy M, Dursun R, Lotti T.
Dermatol Ther. 2020 Nov 4:e14507. doi: 10.1111/dth.14507. Online ahead of print. Review.

5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia.
McCoy J, Cadegiani FA, Wambier CG, Herrera S, Vaño-Galván S, Mesinkovska NA, Ramos PM, Shapiro J, Sinclair R, Tosti A, Goren A.
J Eur Acad Dermatol Venereol. 2020 Nov 2. doi: 10.1111/jdv.17021. Online ahead of print. Retrospective cohort study.

Cutaneous lymphomas and COVID-19: What is known so far?
Elmasry MF, Youssef R, Elbendary A, Helmy K, Abdelkader HA.
Dermatol Ther. 2020 Oct 28. doi: 10.1111/dth.14463. Online ahead of print. Review.

Caring for blind and vision impaired dermatological patients during the COVID-19 pandemic.
Chang MJ, Lipner SR.
Dermatol Ther. 2020 Oct 24. doi: 10.1111/dth.14448. Online ahead of print. Commentary / recommendations.

An evaluation of dermatology patients shielding during the COVID-19 outbreak.
Khan SS, Marshall CL, Stylianou KA, McMullen E, Griffiths CEM, Warren RB, Hunter HJA.
Clin Exp Dermatol. 2020 Oct 24. doi: 10.1111/ced.14489. Online ahead of print. Survey / cross-sectional study.

Alopecia and gray hair are associated with COVID-19 severity.
Ramos PM, Ianhez M, Miot HA.
Exp Dermatol. 2020 Oct 24. doi: 10.1111/exd.14220. Online ahead of print. Survey / cross-sectional study.

Synchronous telemedicine in allergy: Lessons learned and transformation of care during the COVID-19 pandemic.
Thomas I, Siew LQC, Rutkowski K.
J Allergy Clin Immunol Pract. 2020 Oct 19:S2213-2198(20)31124-7. doi: 10.1016/j.jaip.2020.10.013. Online ahead of print. Retrospective cohort study.

Clinical symptoms of hyperandrogenic women diagnosed with COVID-19.
Cadegiani FA, Lim RK, Goren A, McCoy J, Situm M, Kovacevic M, Vañó Galván S, Sinclair R, Tosti A, Wambier CG.
J Eur Acad Dermatol Venereol. 2020 Oct 21. doi: 10.1111/jdv.17004. Online ahead of print. Cross-sectional case-control study.

Cutaneous lymphomas management during a covid- 19 pandemic.
Vitiello P, Sica A, Ronchi A, Pastore F, Casale B, Argenziano G.
G Ital Dermatol Venereol. 2020 Oct 21. doi: 10.23736/S0392-0488.20.06717-6. Online ahead of print. Report / commentary.

The spectrum of dermatoses during the lockdown period of COVID-19 pandemic: Are papulosquamous disorders on the rise?
Singh AK, Rathod D, Gowda V, Bhargava S.
Skinmed. 2020 Aug 1;18(4):255-256. eCollection 2020. Commentary.

An opportunity for improvement: iPLEDGE policy changes during the coronavirus pandemic.
Pathoulas JT, Farah RS, Fiessinger L, Mansh M.
Dermatol Ther. 2020 Oct 14:e14411. doi: 10.1111/dth.14411. Online ahead of print. Commentary.

Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China.
Tao F, Tang X, Tao H, Luo Y, Cao H, Xiang W, Zhao Y, Jin L.
J Diabetes Complications. 2020 Sep;34(9):107622. doi: 10.1016/j.jdiacomp.2020.107622. Epub 2020 May 14. Commentary / recommendations.

Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy.
Randolph M, Al-Alola A, Tosti A.
J Eur Acad Dermatol Venereol. 2020 Oct 12. doi: 10.1111/jdv.16989. Online ahead of print. Commentary.

Impact of COVID-19 on patient-initiated discontinuation of omalizumab in two academic hospital clinics at the University of Toronto.
Seung Kim JH, Georgakopoulos JR, Yeung J.
J Cutan Med Surg. 2020 Sep/Oct;24(5):534-535. doi: 10.1177/1203475420936641. Epub 2020 Jun 17. Retrospective cohort study.

Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men.
Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16953. Online ahead of print. Prospective cohort study.

Androgen receptor genetic variant predicts COVID-19 disease severity: A prospective longitudinal study of hospitalized COVID-19 male patients.
McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16956. Online ahead of print. Prospective cohort study.

Jogger's facial dermatoses- an emerging entity in COVID-19 pandemic.
Singh M, Bhargava S, Pawar M, Jatana G, Maheswari A, Bothra A.
Dermatol Ther. 2020 Sep 10:e14293. doi: 10.1111/dth.14293. Online ahead of print. Research study.

Managing diabetic foot in times of COVID-19: time to put the best 'foot' forward.
Atri A, Kocherlakota CM, Dasgupta R.
Int J Diabetes Dev Ctries. 2020 Sep 1:1-8. doi: 10.1007/s13410-020-00866-9. Online ahead of print. Review.

Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic.
Shahidi Dadras M, Ahmadzadeh Z, Younespour S, Abdollahimajd F.
J Dermatolog Treat. 2020 Sep 5:1-24. doi: 10.1080/09546634.2020.1819528. Online ahead of print. Case-control study.

Strategies to reduce severe diabetic foot infections and complications during epidemics (STRIDE).
Schmidt BM, Munson ME, Rothenberg GM, Holmes CM, Pop-Busui R.
J Diabetes Complications. 2020 Jul 28:107691. doi: 10.1016/j.jdiacomp.2020.107691. Online ahead of print. Longitudinal study.
https://doi.org/10.1016/j.jdiacomp.2020.107691

Clinical characteristics and outcomes in patients with COVID-2019 and leprosy.
Santos VS, Quintans-Júnior LJ, de Souza Barboza W, Antunes de Souza Araújo A, Ricardo Martins-Filho P.
J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16899. Online ahead of print. Cross-sectional study.

COVID-19 and diabetes cutaneous comorbidity.
Zhang M, Gao W.
Metabol Open. 2020 Sep;7:100055. doi: 10.1016/j.metop.2020.100055. Epub 2020 Aug 25. Review / commentary.

Screen rhytides: the cosmetic legacy of COVID-19.
Searle T, Ali FR, Al-Niaimi F.
Dermatol Ther. 2020 Aug 21. doi: 10.1111/dth.14211. Online ahead of print. Commentary.

A multistage combined approach to promote diabetic wound healing in COVID-19 era.
Grande R, Fiori G, Russo G, Fioramonti P, Campagnol M, di Marzo L.
Int Wound J. 2020 Aug 21. doi: 10.1111/iwj.13476. Online ahead of print. Case reports & commentary.

Perceived stress links income loss and urticaria activity during the COVID-19 pandemic.
Shen M, Xiao Y, Yuan Y, Chen X, Li J.
Ann Allergy Asthma Immunol. 2020 Aug 17:S1081-1206(20)30575-5. doi: 10.1016/j.anai.2020.08.019. Online ahead of print. Survey / cross-sectional study.

Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic.
Martínez-Pallás I, Aldea-Manrique B, Ramírez-Lluch M, Vinuesa-Hernando JM, Ara-Martín M.
J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16879. Online ahead of print. Research study / audit.

Fast-track pathway for diabetic foot ulceration during COVID-19 crisis: a document from International Diabetic Foot Care Group and D-Foot International.
Meloni M, Bouillet B, Ahluwalia R, Lüdemann C, Sánchez-Ríos JP, Iacopi E, Lazaro Martinez JL.
Diabetes Metab Res Rev. 2020 Aug 17:e3396. doi: 10.1002/dmrr.3396. Online ahead of print. Commentary / recommendations.

Novel solutions for dermatologic care of geriatric patients and the role of the dermatology house call.
Lipner SR, Ouchida K.
J Am Acad Dermatol. 2020 Aug 13:S0190-9622(20)32423-3. doi: 10.1016/j.jaad.2020.07.128. Online ahead of print. Commentary / recommendations.

Intralesional antigen immunotherapy for warts in the era of COVID-19.
Nofal A, Fawzy MM, Abdelmaksoud A, El-Hawary EE.
J Dermatolog Treat. 2020 Aug 8:1-4. doi: 10.1080/09546634.2020.1808152. Online ahead of print. Commentary / recommendations.

Response to "Patient preference for cellulitis treatment: at-home care is preferred to hospital-based treatment".
Shaw KS, Karagounis TK, Yin L, Gibbon G, Betensky RA, Lo Sicco KI, Femia AN.
J Am Acad Dermatol. 2020 Aug 7:S0190-9622(20)32360-4. doi: 10.1016/j.jaad.2020.07.120. Online ahead of print. Case review / audit.

The COVID-19 outbreak negatively affects the delivery of care for patients with diabetic foot ulcers.
Liu C, You J, Zhu W, Chen Y, Li S, Zhu Y, Ji S, Wang Y, Li H, Li L, Fan S.
Diabetes Care. 2020 Aug 7:dc201581. doi: 10.2337/dc20-1581. Online ahead of print. Research study / case review.

Male balding is a major risk factor for severe COVID-19.
Lee J, Yousaf A, Fang W, Kolodney M.
J Am Acad Dermatol. 2020 Jul 21:S0190-9622(20)32262-3. doi: 10.1016/j.jaad.2020.07.062. Online ahead of print. Cross-sectional study.

Management of patients with Behçet's disease during the COVID-19 pandemic.
Dursun R, Temiz SA, Özer İ, Daye M, Ataseven A.
Dermatol Ther. 2020 Jul 25:e14063. doi: 10.1111/dth.14063. Online ahead of print. Retrospective cohort study.

Response to- management of leprosy patients in era of covid.
Kumar B, Narang T, Dogra S.
Dermatol Ther. 2020 Jul 23:e14052. doi: 10.1111/dth.14052. Online ahead of print. Commentary.

COVID-19 infection in patients with Sézary syndrome: report of two cases.
Gonzaga Y, Batista Fontes Santos M, Silva MM, Nucci M.
Dermatol Ther. 2020 Jul 23:e14042. doi: 10.1111/dth.14042. Online ahead of print. No abstract available. Case reports.

"Cell phone acne" epidemic during COVID-19 pandemic.
Singh M, Pawar M, Maheshwari A, Bothra A, Khunger N.
Clin Exp Dermatol. 2020 Jun 29. doi: 10.1111/ced.14360. [Epub ahead of print]. Case series.

Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire.
Turkmen D, Altunisik N, Sener S, Colak C.
Dermatol Ther. 2020 Jun 28:e13923. doi: 10.1111/dth.13923. [Epub ahead of print]. Survey.

Considerations of managing lichen planopilaris with hydroxychloroquine during the COVID-19 pandemic.
Dadkhahfar S, Araghi F, Tabary M, Moravvej H.
J Drugs Dermatol. 2020 Jun 1;19(6):679-680. No abstract available. Review / commentary.

Facial Abrikosoff tumour: The role of the dermatologist during COVID-19 pandemic.
Orsini D, D'Arino A, Tedesco M, Cota C, Pigliacelli F, Assorgi C, Latini A, Cristaudo A, Morrone A.
Int Wound J. 2020 Jun 23. doi: 10.1111/iwj.13431. [Epub ahead of print] No abstract available. Case report.

Hygienic and cosmetic care habits in polish women during COVID-19 pandemic.
Mościcka P, Chróst N, Terlikowski R, Przylipiak M, Wołosik K, Przylipiak A.
J Cosmet Dermatol. 2020 Jun 23. doi: 10.1111/jocd.13539. [Epub ahead of print]. Survey.

Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions.
Valent P, Akin C, Bonadonna P, Brockow K, Niedoszytko M, Nedoszytko B, Butterfield JH, Alvarez-Twose I, Sotlar K, Schwaab J, Jawhar M, Reiter A, Castells M, Sperr WR, Kluin-Nelemans HC, Hermine O, Gotlib J, Zanotti R, Broesby-Olsen S, Horny HP, Triggiani M, Siebenhaar F, Orfao A, Metcalfe DD, Arock M, Hartmann K.
J Allergy Clin Immunol. 2020 Jun 16. pii: S0091-6749(20)30839-3. doi: 10.1016/j.jaci.2020.06.009. [Epub ahead of print]. Review / recommendations.

Observation and consideration on using of JAKi in clinical trials in times of COVID-19.
Yang J, Maher AM, Li Y, An X, Tao J.
Dermatol Ther. 2020 Jun 15. doi: 10.1111/dth.13831. [Epub ahead of print] No abstract available. Case series.

Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic.
Kutlu Ö, Aktaş H, İmren IG, Metin A.
J Dermatolog Treat. 2020 Jun 13:1-4. doi: 10.1080/09546634.2020.1782820. [Epub ahead of print] No abstract available. Commentary.

Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency.
Ruggiero A, Megna M, Annunziata MC, Abategiovanni L, Scalvenzi M, Tajani A, Fabbrocini G, Villani A.
J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16746. [Epub ahead of print]. Prospective observational study.

Cutaneous autoimmune diseases during COVID 19 pandemic.
Günther C, Aschoff R, Beissert S.
J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16753. [Epub ahead of print]. Review / commentary.

Saving the diabetic foot during the COVID-19 pandemic: A tale of two cities.
Shin L, Bowling FL, Armstrong DG, Boulton AJM.
Diabetes Care. 2020 Jun 12. pii: dc201176. doi: 10.2337/dc20-1176. [Epub ahead of print]. Review & case reports.

Diabetic foot ulceration in COVID-19 lockdown: cause for concern or unexpected benefit?
Lipscomb D, Smith AS, Adamson S, Rezazadeh EM.
Diabet Med. 2020 Jun 12. doi: 10.1111/dme.14340. [Epub ahead of print]. Commentary / audit.

Change of the diagnostic distribution in applicants to dermatology after COVID-19 pandemic: What it whispers to us?
Turan Ç, Metin N, Utlu Z, Öner Ü, Kotan ÖS.
Dermatol Ther. 2020 Jun 12:e13804. doi: 10.1111/dth.13804. [Epub ahead of print]. Cross-sectional study.

Recommendations on trichological treatments during COVID-19 pandemic.
Rossi A, Magri F, Caro G, Federico A, Di Fraia M, Muscianese M, Fortuna MC, Carlesimo M.
J Dermatolog Treat. 2020 Jun 10:1-20. doi: 10.1080/09546634.2020.1781046. [Epub ahead of print]. Review / recommendations.

Post the pandemic: How will COVID-19 transform diabetic foot disease management?
Najafi B.
J Diabetes Sci Technol. 2020 Jun 9:1932296820930290. doi: 10.1177/1932296820930290. [Epub ahead of print] No abstract available. Commentary.

Geriatric skin care in the era of COVID-19.
Golpanian RS, Yosipovitch G.J
Am Geriatr Soc. 2020 Jun 7. doi: 10.1111/jgs.16627. [Epub ahead of print] No abstract available. Commentary / review.

Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy.
Vezzoli P, Di Mercurio M, Carugno A, Gambini DM, Robustelli Test E, Imberti G, Castagna AF, Sena P.
Dermatol Ther. 2020 Jun 7. doi: 10.1111/dth.13776. [Epub ahead of print] No abstract available. Survey / cross-sectional study.

Challenges faced by patients with morphea in the era of SARS-CoV-2.
Shahidi Dadras M, Namazi N, Nikvar M, Abdollahimajd F.
J Dermatolog Treat. 2020 Jun 5:1-6. doi: 10.1080/09546634.2020.1775771. [Epub ahead of print] No abstract available. Commentary.

Recommendations for management of diabetic foot ulcers during COVID-19 outbreak.
Kelahmetoglu O, Camlı MF, Kirazoglu A, Erbayat Y, Asgarzade S, Durgun U, Mehdizade T, Yeniocak A, Yildiz K, Sonmez Ergun S, Guneren E.
Int Wound J. 2020 Jun 5. doi: 10.1111/iwj.13416. [Epub ahead of print]. Review / recommendations.

Management of diabetic persons with foot ulceration during COVID-19 health care emergency: effectiveness of a new triage pathway.
Marco M, Valentina I, Laura G, Roberto G, Luigi U.
Diabetes Res Clin Pract. 2020 Jun 1:108245. doi: 10.1016/j.diabres.2020.108245. [Epub ahead of print]. Cohort study.

Teledermatology for acne patients: how to reduce face-to-face visits during COVID-19 pandemic.
Villani A, Annunziata MC, Abategiovanni L, Fabbrocini G.
J Cosmet Dermatol. 2020 Jun 3. doi: 10.1111/jocd.13519. [Epub ahead of print]. Report / commentary.

Psoriatic arthritis and COVID-19 pandemic: Consequences in medical treatment?
Wollina U, Fioranelli M, Goldust M, Lotti T.
Dermatol Ther. 2020 Jun 1:e13743. doi: 10.1111/dth.13743. [Epub ahead of print]. Review.

Recommendations for diagnosis and treatment of onychomycosis during the COVID-19 pandemic.
Lipner SR, Ricardo JW.
Dermatol Ther. 2020 May 30:e13709. doi: 10.1111/dth.13709. [Epub ahead of print] No abstract available. Review / recommendations.

The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
Dursun R, Temiz SA.
Dermatol Ther. 2020 May 31:e13730. doi: 10.1111/dth.13730. [Epub ahead of print]. Retrospective case review.

Impact of Covid 19 pandemic on obsessive compulsive and related disorder patients- Psychodermatological perspectives.
Hafi B, Uvais NA, Jafferany M, Afra TP, Muhammed Razmi T.
Dermatol Ther. 2020 May 30. doi: 10.1111/dth.13736. [Epub ahead of print] No abstract available. Commentary.

Palliative psychodermatology care during COVID-19 pandemic.
Hafi B, Uvais NA, Jafferany M, Afra TP, Muhammed RT.
Dermatol Ther. 2020 May 30. doi: 10.1111/dth.13732. [Epub ahead of print] No abstract available. Commentary.

Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity.
Minniti A, Maglione W, Pignataro F, Cappadona C, Caporali R, Del Papa N.
Clin Rheumatol. 2020 May 27. doi: 10.1007/s10067-020-05191-4. [Epub ahead of print] Report / commentary.

Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.
Mathian A, Amoura Z.
Ann Rheum Dis. 2020 May 25. pii: annrheumdis-2020-217859. doi: 10.1136/annrheumdis-2020-217859. [Epub ahead of print] No abstract available. Commentary.

Are patients with systemic lupus erythematosus at increased risk for COVID-19?
Favalli EG, Gerosa M, Murgo A, Caporali R.
Ann Rheum Dis. 2020 May 25. pii: annrheumdis-2020-217787. doi: 10.1136/annrheumdis-2020-217787. [Epub ahead of print] No abstract available. Survey / cross-sectional study.

Two false negative test results in a symptomatic patient with a confirmed case of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and suspected Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).
Lagziel T, Quiroga L, Ramos M, Hultman CS, Asif M.
Cureus. 2020 May 19;12(5):e8198. doi: 10.7759/cureus.8198. Case report.

COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy.
de Freitas Ferreira ACA, Romão TT, SIlva Macedo Y, Pupe C, Nascimento OJ.
Eur J Neurol. 2020 May 24. doi: 10.1111/ene.14361. [Epub ahead of print]. Case report.

Androgenetic alopecia present in the majority of hospitalized COVID-19 patients - the "Gabrin sign".
Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Pascual PF, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A.
J Am Acad Dermatol. 2020 May 21. pii: S0190-9622(20)30948-8. doi: 10.1016/j.jaad.2020.05.079. [Epub ahead of print] No abstract available. Cross-sectional study.

Management of telogen effluvium during the Covid-19 emergency: Psychological implications.
Rivetti N, Barruscotti S.
Dermatol Ther. 2020 May 22:e13648. doi: 10.1111/dth.13648. [Epub ahead of print] No abstract available. Commentary / review.

Management of leprosy patients in the era of COVID19.
Abdelmaksoud A, Gupta SK.
Dermatol Ther. 2020 May 22:e13631. doi: 10.1111/dth.13631. [Epub ahead of print] No abstract available. Review / recommendations.

Immunosuppressive treatment for systemic sclerosis - therapeutic challenges during the COVID-19 pandemic.
Blicharz L, Czuwara J, Samochocki Z, Goldust M, Olszewska M, Rudnicka L.
Dermatol Ther. 2020 May 19:e13619. doi: 10.1111/dth.13619. [Epub ahead of print] No abstract available. Commentary.

Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.
Fortuné C, Gietzen A, et al.; Scleroderma Patient-centered Intervention Network (SPIN); COVID-19 Patient Advisory Team.
J Psychosom Res. 2020 May 14:110132. doi: 10.1016/j.jpsychores.2020.110132. [Epub ahead of print]. Trial protocol.

Could patients taking isotretinoin therapy be immune against SARS-COV-2?
Elgarhy LH.
Dermatol Ther. 2020 May 13. doi: 10.1111/dth.13573. [Epub ahead of print] No abstract available. Letter.

Recommendations for treatment of nail lichen planus during the COVID-19 pandemic.
Ricardo JW, Lipner SR.
Dermatol Ther. 2020 May 10:e13551. doi: 10.1111/dth.13551. [Epub ahead of print] No abstract available. Commentary.

Systemic isotretinoin therapy in the era of COVID19.
Abdelmaksoud A, Vestita M, El-Amawy HS, Ayhan E, An İ, Öztürk M, Goldust M.
Dermatol Ther. 2020 May 1:e13482. doi: 10.1111/dth.13482. [Epub ahead of print] No abstract available. Commentary.

Calm before the storm: understanding the role of JAK inhibitors in COVID-19.
Peterson D, Damsky W, King B.
J Am Acad Dermatol. 2020 Apr 25. pii: S0190-9622(20)30713-1. doi: 10.1016/j.jaad.2020.04.097. [Epub ahead of print] No abstract available. Letter.

Chronic cutaneous ulcers management in dermatologic department during COVID-19 era.
Zagaria O, Ruggiero A, Cinelli E, Marasca C, Monfrecola A, Fabbrocini G.
Int Wound J. 2020 Apr 28. doi: 10.1111/iwj.13385. [Epub ahead of print] No abstract available. Letter.

Potential role of Janus kinase inhibitors in COVID-19.
Napolitano M, Fabbrocini G, Patruno C.
J Am Acad Dermatol. 2020 Apr 24. pii: S0190-9622(20)30714-3. doi: 10.1016/j.jaad.2020.04.098. [Epub ahead of print] No abstract available. Letter.

Wound center without walls: The new model of providing care during the COVID-19 pandemic.
Rogers LC, Armstrong DG, Capotorto J, Fife CE, Garcia JR, Gelly H, Gurtner GC, Lavery LA, Marston W, Neville R, Nusgart M, Ravitz K, Woelfel S.
Wounds. 2020 Apr 24. pii: WNDS20200420-1. [Epub ahead of print]

Mass quarantine measures in the time of COVID-19 pandemic: psycho-social implications for chronic skin conditions and a call for qualitative studies.
Garcovich S, Bersani FS, Chiricozzi A, De Simone C.
J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16535. [Epub ahead of print]

Phototherapeutic approach to dermatological patients during the 2019 coronavirus pandemic: Real-life data from the Italian Red Zone.
Pacifico A, Ardigò M, Frascione P, Damiani G, Morrone A.
Br J Dermatol. 2020 Apr 17. doi: 10.1111/bjd.19145. [Epub ahead of print]

The use of Janus kinase inhibitors in the time of SARS-CoV-2.
Peterson D, Damsky W, King B.
J Am Acad Dermatol. 2020 Apr 9. pii: S0190-9622(20)30522-3. doi: 10.1016/j.jaad.2020.03.099. [Epub ahead of print] No abstract available.

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
Sawalha AH, Zhao M, Coit P, Lu Q.
Clin Immunol. 2020 Apr 7:108410. doi: 10.1016/j.clim.2020.108410. [Epub ahead of print]

Back to CEBD Coronavirus Dermatology Resource Homepage

糖心原创

CEBD Coronavirus Dermatology Resource

Journal articles - Coronavirus and specific patient groups other than psoriasis

Contents

Atopic dermatitis

Skin cancers

Hidradenitis suppurativa

Bullous diseases

Paediatric

Other conditions and groups

Centre of Evidence Based Dermatology

Legal information

Get social